Lam Research (LRCX) 10-Q 3 Nov 14 2015 Q1 Quarterly report Financial data

Document_and_Entity_Informatio

Document and Entity Information	3 Months Ended
	Sep. 28, 2014	Oct. 28, 2014
Document Information [Line Items]	'	'
Document Type	'10-Q	'
Amendment Flag	'false	'
Document Period End Date	28-Sep-14	'
Document Fiscal Year Focus	'2015	'
Document Fiscal Period Focus	'Q1	'
Trading Symbol	'LRCX	'
Entity Registrant Name	'LAM RESEARCH CORP	'
Entity Central Index Key	'0000707549	'
Current Fiscal Year End Date	'--06-28	'
Entity Filer Category	'Large Accelerated Filer	'
Entity Common Stock, Shares Outstanding	'	158,960,476

Consolidated_Balance_Sheets

Consolidated Balance Sheets (USD $)	Sep. 28, 2014	Jun. 29, 2014
In Thousands, unless otherwise specified
ASSETS	'	'
Cash and cash equivalents	$1,293,678	$1,452,677	[1]
Short-term investments	1,593,668	1,612,967	[1]
Accounts receivable, less allowance for doubtful accounts of $4,917 as of September 28, 2014 and $4,962 as of June 29, 2014	864,403	800,616	[1]
Inventories	815,612	740,503	[1]
Prepaid expenses and other current assets	123,615	176,899	[1]
Total current assets	4,690,976	4,783,662	[1]
Property and equipment, net	555,658	543,496	[1]
Restricted cash and investments	149,483	146,492	[1]
Goodwill	1,467,319	1,466,225	[1]
Intangible assets, net	854,834	894,078	[1]
Other assets	175,558	159,353	[1]
Total assets	7,893,828	7,993,306	[1]
LIABILITIES AND STOCKHOLDERS' EQUITY	'	'
Trade accounts payable	249,779	223,515	[1]
Accrued expenses and other current liabilities	578,968	604,296	[1]
Deferred profit	251,779	235,923	[1]
Current portion of long-term debt, convertible notes, and capital leases	519,099	518,267	[1]
Total current liabilities	1,599,625	1,582,001	[1]
Long-term debt, convertible notes, and capital leases	824,269	817,202	[1]
Income taxes payable	217,118	258,357	[1]
Other long-term liabilities	179,711	122,662	[1]
Total liabilities	2,820,723	2,780,222	[1]
Commitments and contingencies	'	'	[1]
Senior convertible notes	182,432	183,349	[1]
Stockholders' equity:	'	'
Preferred stock, at par value of $0.001 per share; authorized - 5,000 shares; none outstanding	'	'	[1]
Common stock, at par value of $0.001 per share; authorized - 400,000 shares; issued and outstanding - 159,384 shares as of September 28, 2014 and 162,350 shares as of June 29, 2014	159	162	[1]
Additional paid-in capital	5,291,844	5,239,567	[1]
Treasury stock, at cost; 96,386 shares as of September 28, 2014 and 92,867 shares as of June 29, 2014	-4,050,035	-3,757,076	[1]
Accumulated other comprehensive loss	-38,732	-28,655	[1]
Retained earnings	3,687,437	3,575,737	[1]
Total stockholders' equity	4,890,673	5,029,735	[1]
Total liabilities and stockholders' equity	$7,893,828	$7,993,306	[1]
[1]	Derived from audited financial statements

Consolidated_Balance_Sheets_Pa

Consolidated Balance Sheets (Parenthetical) (USD $)	Sep. 28, 2014	Jun. 29, 2014
In Thousands, except Per Share data, unless otherwise specified
Accounts receivable, allowance for doubtful accounts	$4,917	$4,962	[1]
Preferred stock, par value	$0.00	$0.00	[1]
Preferred stock, shares authorized	5,000	5,000	[1]
Preferred stock, shares outstanding	0	0	[1]
Common stock, par value	$0.00	$0.00	[1]
Common stock, shares authorized	400,000	400,000	[1]
Common stock, shares issued	159,384	162,350	[1]
Common stock, shares outstanding	159,384	162,350	[1]
Treasury stock, shares	96,386	92,867	[1]
[1]	Derived from audited financial statements

Condensed_Consolidated_Stateme

Condensed Consolidated Statements of Operations (USD $)	3 Months Ended
In Thousands, except Per Share data, unless otherwise specified	Sep. 28, 2014	Sep. 29, 2013
Revenue	$1,152,368	$1,015,059
Cost of goods sold	646,829	583,201
Gross margin	505,539	431,858
Research and development	188,934	170,567
Selling, general and administrative	148,307	155,883
Total operating expenses	337,241	326,450
Operating income	168,298	105,408
Other expense, net	-5,648	-14,262
Income before income taxes	162,650	91,146
Income tax expense	21,569	5,640
Net income	$141,081	$85,506
Net income per share:	'	'
Basic	$0.87	$0.52
Diluted	$0.80	$0.50
Number of shares used in per share calculations:	'	'
Basic	161,685	162,896
Diluted	177,118	171,363
Cash dividend declared per common share	$0.18	'

Condensed_Consolidated_Stateme1

Condensed Consolidated Statements of Comprehensive Income (USD $)	3 Months Ended
In Thousands, unless otherwise specified	Sep. 28, 2014	Sep. 29, 2013
Net income	$141,081	$85,506
Other comprehensive income, net of tax:	'	'
Foreign currency translation adjustment	-8,959	3,559
Cash flow hedges:	'	'
Net unrealized gains during the period	298	4,507
Net losses reclassified into earnings	-102	-3,802
Net change	196	705
Available-for-sale investments:	'	'
Net unrealized (losses) gains during the period	-1,759	686
Net gains reclassified into earnings	379	74
Net change	-1,380	760
Defined benefit plan, net change in unrealized component	66	314
Net current-period other comprehensive (loss) income	-10,077	5,338
Comprehensive income	$131,004	$90,844

Condensed_Consolidated_Stateme2

Condensed Consolidated Statements of Cash Flows (USD $)	3 Months Ended
In Thousands, unless otherwise specified	Sep. 28, 2014		Sep. 29, 2013
CASH FLOWS FROM OPERATING ACTIVITIES:	'		'
Net income	$141,081		$85,506
Adjustments to reconcile net income to net cash provided by operating activities:	'		'
Depreciation and amortization	67,885		74,331
Deferred income taxes	3,186		'
Impairment of long-lived asset	'		7,004
Equity-based compensation expense	32,040		23,235
Income tax benefit on equity-based compensation plans	9,861		'
Excess tax benefit on equity-based compensation plans	-10,404		'
Gain on sale of business	-7,431		'
Amortization of convertible note discount	8,509		8,122
Other, net	5,526		4,115
Changes in operating assets and liabilities	-109,092		-150,388
Net cash provided by operating activities	141,161		51,925
CASH FLOWS FROM INVESTING ACTIVITIES:	'		'
Capital expenditures	-41,871		-23,778
Cash paid for business acquisition	-1,137		'
Purchases of available-for-sale securities	-337,100		-156,409
Sales and maturities of available-for-sale securities	346,745		198,976
Proceeds from sale of business	41,212		'
Transfer of restricted cash and investments	22		150
Net cash provided by investing activities	7,871		18,939
CASH FLOWS FROM FINANCING ACTIVITIES:	'		'
Principal payments on long-term debt and capital lease obligations	-107		-88
Excess tax benefit on equity-based compensation plans	10,404		'
Treasury stock purchases	-308,422		-104,285
Dividends paid	-29,240		'
Reissuances of treasury stock related to employee stock purchase plan	16,919		15,154
Proceeds from issuance of common stock	4,609		12,574
Net cash used for financing activities	-305,837		-76,645
Effect of exchange rate changes on cash	-2,194		-508
Net decrease in cash and cash equivalents	-158,999		-6,289
Cash and cash equivalents at beginning of period	1,452,677	[1]	1,162,473
Cash and cash equivalents at end of period	$1,293,678		$1,156,184
[1]	Derived from audited financial statements

BASIS_OF_PRESENTATION

BASIS OF PRESENTATION	3 Months Ended
	Sep. 28, 2014
BASIS OF PRESENTATION	'
	NOTE 1 — BASIS OF PRESENTATION
	The accompanying unaudited Condensed Consolidated Financial Statements have been prepared in accordance with U.S. generally accepted accounting principles (“GAAP”) for interim financial information and the instructions to Article 10 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by GAAP for complete financial statements. In the opinion of management, all adjustments (consisting only of normal recurring adjustments) considered necessary for a fair presentation have been included. The accompanying unaudited Condensed Consolidated Financial Statements should be read in conjunction with the audited Consolidated Financial Statements of Lam Research Corporation (“Lam Research” or the “Company”) for the fiscal year ended June 29, 2014, which are included in the Company’s Annual Report on Form 10-K as of and for the year ended June 29, 2014 (the “2014 Form 10-K”). The Company’s Forms 10-K, Forms 10-Q and Forms 8-K are available online at the Securities and Exchange Commission website on the Internet. The address of that site is www.sec.gov. The Company also posts its Forms 10-K, Forms 10-Q and Forms 8-K on its corporate website at http://investor.lamresearch.com.
	The consolidated financial statements include the accounts of Lam Research and its wholly owned subsidiaries. All intercompany accounts and transactions have been eliminated in consolidation. The Company’s reporting period is a 52/53-week fiscal year. The Company’s current fiscal year will end June 28, 2015 and includes 52 weeks. The quarters ended September 28, 2014 (the “September 2014 quarter”) and September 29, 2013 (the “September 2013 quarter”) included 13 weeks.

RECENT_ACCOUNTING_PRONOUNCEMEN

RECENT ACCOUNTING PRONOUNCEMENTS	3 Months Ended
	Sep. 28, 2014
RECENT ACCOUNTING PRONOUNCEMENTS	'
	NOTE 2 — RECENT ACCOUNTING PRONOUNCEMENTS
	In July 2013, the FASB released Accounting Standards Update 2013-11 “Presentation of an Unrecognized Tax Benefit When a Net Operating Loss Carryforward, a Similar Tax Loss, or a Tax Credit Carryforward Exists.” The new standard requires that an unrecognized tax benefit should be presented as a reduction of a deferred tax asset for a net operating loss carryforward or other tax credit carryforward when settlement in this manner is available under the tax law. The Company adopted this standard during the fiscal quarter without significant impact on its financial position, results of operations, or cash flows.
	In April 2014, the FASB released Accounting Standards Update 2014-8 “Presentation of Financial Statements and Property, Plant and Equipment: Reporting Discontinued Operations and Disclosure of Disposals of Components of an Entity.” The new standard re-defines discontinued operations and requires only those disposals of components of an entity, including classifications as held for sale, that represent a strategic shift that has, or will have, a major effect on an entity’s operations and financial results to be reported as discontinued operations. In addition, the new standard expands the disclosure requirements of discontinued operations. The Company adopted this standard during the fiscal quarter with no impact on its financial position.
	In May 2014, the FASB released Accounting Standards Update 2014-9 “Revenue from Contracts with Customers” to supersede nearly all existing revenue recognition guidance under GAAP. The core principle of the standard is to recognize revenues when promised goods or services are transferred to customers in an amount that reflects the consideration that is expected to be received for those goods or services. The new standard defines a five step process to achieve this core principle and, in doing so, it is possible more judgment and estimates may be required within the revenue recognition process than required under existing GAAP including identifying performance obligations in the contract, estimating the amount of variable consideration to include in the transaction price and allocating the transaction price to each separate performance obligation. The Company is required to adopt this standard starting in the first quarter of fiscal year 2018 using either of two methods: (i) retrospective to each prior reporting period presented with the option to elect certain practical expedients as defined within the standard; or (ii) retrospective with the cumulative effect of initially applying the standard recognized at the date of initial application and providing certain additional disclosures as defined per the standard. The Company has not yet selected a transition method, and has not determined the impact that the new standard will have on its consolidated financial statements.

EQUITYBASED_COMPENSATION_PLANS

EQUITY-BASED COMPENSATION PLANS	3 Months Ended
	Sep. 28, 2014
EQUITY-BASED COMPENSATION PLANS	'
	NOTE 3 — EQUITY-BASED COMPENSATION PLANS
	The Company has stock plans that provide for grants of equity-based awards to eligible participants, including stock options and restricted stock units (“RSUs”), of Lam Research common stock (“Common Stock”). An option is a right to purchase Common Stock at a set price. An RSU award is an agreement to issue shares of Common Stock at the time of vesting. The Company’s options and RSU awards typically vest over a period of three years or less, although awards assumed in connection with the acquisition of Novellus Systems, Inc. (“Novellus”), have vesting terms up to four years. The Company also has an employee stock purchase plan that allows employees to purchase its Common Stock at a discount through payroll deductions.
	The Company recognized the following equity-based compensation expense and related income tax benefit in the Condensed Consolidated Statements of Operations:
		Three Months Ended
		September 28,			September 29,
		2014			2013
		(in millions)
	Equity-based compensation expense	$	32		$	23.2
	Income tax benefit related to equity-based compensation expense	$	4.7		$	3.9
	The estimated fair value of the Company’s stock-based awards, less expected forfeitures, is amortized over the awards’ vesting term on a straight-line basis.
	Stock Options and RSUs
	The Lam Research Corporation 2007 Stock Incentive Plan and 2011 Stock Incentive Plan (collectively the “Stock Plans”) provide for the grant of non-qualified equity-based awards to eligible employees, consultants and advisors, and non-employee directors of the Company and its subsidiaries. A summary of stock plan transactions is as follows:
		Options Outstanding						Restricted Stock Units
								Outstanding
		Number of			Weighted-			Number of			Weighted-
		Shares			Average			Shares			Average
					Exercise						Fair
					Price						Market
											Value at
											Grant
	29-Jun-14		1,331,886		$	32.2			5,635,469		$	45.83
	Granted		—		$	—			67,439		$	65.92
	Exercised		(165,696	)	$	27.81			N/A			N/A
	Cancelled		(7,452	)	$	29.86			(57,295	)	$	44.54
	Vested restricted stock		N/A			N/A			(387,148	)	$	41.9
	28-Sep-14		1,158,738		$	32.84			5,258,465		$	46.39
	As of September 28, 2014, there was $3.4 million of total unrecognized compensation cost related to unvested stock options granted and outstanding; that cost is expected to be recognized over a weighted-average remaining vesting period of 1.5 years. As of September 28, 2014, there was $154.2 million of total unrecognized compensation expense related to unvested RSUs granted; that expense is expected to be recognized over a weighted-average remaining period of 1.8 years.
	ESPP
	The 1999 Employee Stock Purchase Plan, as amended and restated (the “1999 ESPP”), allows employees to designate a portion of their base compensation to be withheld through payroll deductions and used to purchase Common Stock at a purchase price per share equal to the lower of 85% of the fair market value of Common Stock on the first or last day of the applicable purchase period. Each offering period generally lasts up to 12 months and includes up to three interim purchase dates.
	Purchase rights under the 1999 ESPP were valued using the Black-Scholes option valuation model and the following weighted-average assumptions for the three months ended September 28, 2014 and September 29, 2013:
		Three Months Ended
		September 28,			September 29,
		2014			2013
	Expected term (years)		0.68			0.66
	Expected stock price volatility		29.07	%		31.43	%
	Risk-free interest rate		0.07	%		0.11	%
	Dividend Yield		0.29	%		—
	As of September 28, 2014, there was $13.2 million of unrecognized compensation expense related to the 1999 ESPP, which is expected to be recognized over a remaining period of approximately 11 months.

FINANCIAL_INSTRUMENTS

FINANCIAL INSTRUMENTS	3 Months Ended
	Sep. 28, 2014
FINANCIAL INSTRUMENTS	'
	NOTE 4 — FINANCIAL INSTRUMENTS
	The Company maintains an investment portfolio of various holdings, types, and maturities. The Company’s mutual funds, which are related to the Company’s obligations under the deferred compensation plan, are classified as trading securities. Investments classified as trading securities are recorded at fair value based upon quoted market prices. Differences between the cost and fair value of trading securities are recognized as other income (expense) in the Condensed Consolidated Statements of Operations. All of the Company’s other short-term investments are classified as available-for-sale and consequently are recorded in the Consolidated Balance Sheets at fair value with unrealized gains or losses reported as a separate component of accumulated other comprehensive income (loss), net of tax.
	Fair Value
	The Company defines fair value as the price that would be received from selling an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. When determining the fair value measurements for assets and liabilities required or permitted to be recorded at fair value, the Company considers the principal or most advantageous market in which it would transact, and it considers assumptions that market participants would use when pricing the asset or liability.
	A fair value hierarchy has been established that prioritizes the inputs to valuation techniques used to measure fair value. The level of an asset or liability in the hierarchy is based on the lowest level of input that is significant to the fair value measurement. Assets and liabilities carried at fair value are classified and disclosed in one of the following three categories:
	Level 1: Valuations based on quoted prices in active markets for identical assets or liabilities with sufficient volume and frequency of transactions.
	Level 2: Valuations based on observable inputs other than Level 1 prices such as quoted prices for similar assets or liabilities, quoted prices in markets that are not active, or model-derived valuations techniques for which all significant inputs are observable in the market or can be corroborated by observable market data, for substantially the full term of the assets or liabilities.
	Level 3: Valuations based on unobservable inputs to the valuation methodology that are significant to the measurement of fair value of assets or liabilities and based on non-binding, broker-provided price quotes and may not have been corroborated by observable market data.
	The Company’s primary financial instruments include its cash, cash equivalents, short-term investments, restricted cash and investments, long-term investments, accounts receivable, accounts payable, long-term debt and capital leases, and foreign currency related derivatives. The estimated fair value of cash, accounts receivable and accounts payable approximates their carrying value due to the short period of time to their maturities. The estimated fair values of capital lease obligations approximate their carrying value as the substantial majority of these obligations have interest rates that adjust to market rates on a periodic basis. Refer to Note 12 for additional information regarding the fair value of the Company’s convertible notes.
	The following table sets forth the Company’s cash, cash equivalents, short-term investments, restricted cash and investments, and other assets measured at fair value on a recurring basis at September 28, 2014 and June 29, 2014:
		September 28, 2014
		Cost				Unrealized				Unrealized			Fair Value				(Reported Within)
						Gain				(Loss)							Cash and Cash			Short-Term			Restricted		Other
																	Equivalents			Investments			Cash &		Assets
																							Investments
		(in thousands)
	Cash	$	286,534			$	—			$	—		$	286,534			$	280,665		$	—		$	5,869		—
	Level 1:
	Time Deposit		132,549				—				—			132,549				—			—			132,549		—
	Money Market Funds		1,013,013				—				—			1,013,013				1,013,013			—			—		—
	US Treasury and Agencies		241,522				178				(98	)		241,602				—			230,537			11,065		—
	Mutual Funds		20,071				3,635				—			23,706				—			—			—		23,706
	Level 1 Total	$	1,407,155			$	3,813			$	(98	)	$	1,410,870			$	1,013,013		$	230,537		$	143,614	$	23,706
	Level 2:
	Municipal Notes and Bonds		252,846				794				(12	)		253,628				—			253,628			—		—
	Government-Sponsored Enterprises		54,449				39				(68	)		54,420				—			54,420			—		—
	Foreign Government Bonds		34,192				26				(46	)		34,172				—			34,172			—		—
	Corporate Notes and Bonds		888,871				1,194				(1,099	)		888,966				—			888,966			—		—
	Mortgage Backed Securities — Residential		24,288				76				(152	)		24,212				—			24,212			—		—
	Mortgage Backed Securities — Commercial		108,165				117				(549	)		107,733				—			107,733			—		—
	Level 2 Total	$	1,362,811			$	2,246			$	(1,926	)	$	1,363,131			$	—		$	1,363,131		$	—	$	—
	Total	$	3,056,500			$	6,059			$	(2,024	)	$	3,060,535			$	1,293,678		$	1,593,668		$	149,483	$	23,706
		June 29, 2014
		Cost				Unrealized				Unrealized			Fair Value				(Reported Within)
						Gain				(Loss)							Cash and Cash			Short-Term			Restricted		Other
																	Equivalents			Investments			Cash &		Assets
																							Investments
		(in thousands)
	Cash	$	285,031			$	—			$	—		$	285,031			$	279,126		$	—		$	5,905		—
	Level 1:
	Time Deposit		132,549				—				—			132,549				—			—			132,549		—
	Money Market Funds		1,168,261				—				—			1,168,261				1,168,261			—			—		—
	US Treasury and Agencies		212,436				178				(27	)		212,587				—			204,549			8,038		—
	Mutual Funds		18,784				2,974				—			21,758				—			—			—		21,758
	Level 1 Total	$	1,532,030			$	3,152			$	(27	)	$	1,535,155			$	1,168,261		$	204,549		$	140,587	$	21,758
	Level 2:
	Municipal Notes and Bonds		334,329				1,108				(4	)		335,433				5,290			330,143			—		—
	Government-Sponsored Enterprises		27,666				41				(15	)		27,692				—			27,692			—		—
	Foreign Government Bonds		35,438				57				(28	)		35,467				—			35,467			—		—
	Corporate Notes and Bonds		874,540				2,034				(335	)		876,239				—			876,239			—		—
	Mortgage Backed Securities — Residential		27,067				59				(182	)		26,944				—			26,944			—		—
	Mortgage Backed Securities — Commercial		112,642				100				(809	)		111,933				—			111,933			—		—
	Level 2 Total	$	1,411,682			$	3,399			$	(1,373	)	$	1,413,708			$	5,290		$	1,408,418		$	—	$	—
	Total	$	3,228,743			$	6,551			$	(1,400	)	$	3,233,894			$	1,452,677		$	1,612,967		$	146,492	$	21,758
	The Company accounts for its investment portfolio at fair value. Realized gains (losses) for investment sales are specifically identified. Management assesses the fair value of investments in debt securities that are not actively traded through consideration of interest rates and their impact on the present value of the cash flows to be received from the investments. The Company also considers whether changes in the credit ratings of the issuer could impact the assessment of fair value. The Company did not recognize any losses on investments due to other-than-temporary impairments during the three months ended September 28, 2014 or September 29, 2013. Additionally, gross realized gains and gross realized (losses) from sales of investments were approximately $0.5 million and $(0.6) million, respectively, in the three months ended September 28, 2014 and $0.2 million and $(0.6) million, respectively, in the three months ended September 29, 2013.
	The following is an analysis of the Company’s cash, cash equivalents, short-term investments and restricted cash and investments in unrealized loss positions:
		September 28, 2014
		Unrealized Losses Less								Unrealized Losses							Total
		Than 12 Months								12 Months or Greater
		Fair Value				Gross				Fair			Gross				Fair Value			Gross
						Unrealized				Value			Unrealized							Unrealized
						Loss							Loss							Loss
		(in thousands)
Municipal Notes and Bonds	$	13,717			$	(12	)		$	—		$	—			$	13,717		$	(12	)
US Treasury & Agencies		58,326				(98	)			—			—				58,326			(98	)
Government-Sponsored Enterprises		36,960				(68	)			—			—				36,960			(68	)
Foreign Government Bonds		20,566				(46	)			—			—				20,566			(46	)
Corporate Notes and Bonds		431,132				(1,072	)			3,525			(27	)			434,657			(1,099	)
Mortgage Backed Securities — Residential		4,252				(83	)			4,487			(69	)			8,739			(152	)
Mortgage Backed Securities — Commercial		69,068				(308	)			19,362			(241	)			88,430			(549	)
	$	634,021			$	(1,687	)		$	27,374		$	(337	)		$	661,395		$	(2,024	)
The amortized cost and fair value of cash equivalents, short-term investments and restricted investments with contractual maturities are as follows as of September 28, 2014:
	Cost				Estimated
					Fair
					Value
	(in thousands)
Due in one year or less	$	1,312,967			$	1,313,292
Due after one year through five years		1,138,825				1,139,517
Due in more than five years		298,103				297,486
	$	2,749,895			$	2,750,295
Management has the ability, if necessary, to liquidate its investments in order to meet the Company’s liquidity needs in the next 12 months. Accordingly, those investments with contractual maturities greater than one year from the date of purchase nonetheless are classified as short-term on the accompanying Consolidated Balance Sheets.
Derivative Instruments and Hedging
The Company carries derivative financial instruments (“derivatives”) on its Consolidated Balance Sheets at their fair values. The Company enters into foreign currency forward contracts with financial institutions with the primary objective of reducing volatility of earnings and cash flows related to foreign currency exchange rate fluctuations. The counterparties to these forward contracts are large global financial institutions that the Company believes are creditworthy, and therefore, it does not consider the risk of counterparty nonperformance to be material.
Cash Flow Hedges
The Company’s financial position is routinely subjected to market risk associated with foreign currency exchange rate fluctuations on non-U.S. dollar transactions or cash flows, primarily from Japanese yen-denominated revenues and euro-denominated expenses. The Company’s policy is to mitigate the foreign exchange risk arising from the fluctuations in the value of these non-U.S. dollar denominated transactions or cash flows through a foreign currency cash flow hedging program, using forward contracts that generally expire within 12 months and no later than 24 months. These foreign currency forward contracts are designated as cash flow hedges and are carried on the Company’s balance sheet at fair value with the effective portion of the contracts’ gains or losses included in accumulated other comprehensive income (loss) and subsequently recognized in revenue/expense in the same period the hedged items are recognized.
At inception and at each quarter end, hedges are tested prospectively and retrospectively for effectiveness using regression analysis. Changes in the fair value of the forward contracts due to changes in time value are excluded from the assessment of effectiveness and are recognized in revenue or expense in the current period. The change in time value related to these contracts was not material for all reported periods. To qualify for hedge accounting, the hedge relationship must meet criteria relating both to the derivative instrument and the hedged item. These criteria include identification of the hedging instrument, the hedged item, the nature of the risk being hedged and how the hedging instrument’s effectiveness in offsetting the exposure to changes in the hedged item’s fair value or cash flows will be measured. There were no gains or losses during the three months ended September 28, 2014 or September 29, 2013 associated with ineffectiveness or forecasted transactions that failed to occur.
To receive hedge accounting treatment, all hedging relationships are formally documented at the inception of the hedge and the hedges must be tested to demonstrate an expectation of providing highly effective offsetting changes to future cash flows on hedged transactions. When derivative instruments are designated and qualify as effective cash flow hedges, the Company recognizes effective changes in the fair value of the hedging instrument within accumulated other comprehensive income (loss) until the hedged exposure is realized. Consequently, with the exception of excluded time value and hedge ineffectiveness recognized, the Company’s results of operations are not subject to fluctuation as a result of changes in the fair value of the derivative instruments. If hedges are not highly effective or if the Company does not believe that the underlying hedged forecasted transactions will occur, the Company may not be able to account for its derivative instruments as cash flow hedges. If this were to occur, future changes in the fair values of the Company’s derivative instruments would be recognized in earnings. Additionally, related amounts previously recorded in other comprehensive income would be reclassified to income immediately. At September 28, 2014, the Company had gains of $0.1 million accumulated in other comprehensive income, which it expects to reclassify from other comprehensive income into earnings over the next 12 months.
Balance Sheet Hedges
The Company also enters into foreign currency forward contracts to hedge fluctuations associated with foreign currency denominated monetary assets and liabilities, primarily third party accounts receivables, accounts payables and intercompany receivables and payables. These forward contracts are not designated for hedge accounting treatment. Therefore, the change in fair value of these derivatives is recorded as a component of other income (expense) and offsets the change in fair value of the foreign currency denominated assets and liabilities, which are also recorded in other income (expense).
As of September 28, 2014, the Company had the following outstanding foreign currency forward contracts that were entered into under its cash flow and balance sheet hedge program:
	Derivatives Designated as								Derivatives Not Designated as
	Hedging Instruments:								Hedging Instruments:
	(in thousands)
Foreign Currency Forward Contracts
	Buy Contracts				Sell Contracts				Buy Contracts			Sell Contracts
Japanese Yen	$	—			$	58,868			$	—		$	21,379
Swiss Franc		—				—				6,684			—
Euro		59,270				—				22,430			—
Korean Won		—				—				12,564			—
Taiwan Dollar		—				—				33,487			—
	$	59,270			$	58,868			$	75,165		$	21,379
The fair value of derivative instruments in the Company’s Consolidated Balance Sheets as of September 28, 2014 and June 29, 2014 were as follows:
	September 28, 2014											June 29, 2014
	Fair Value of Derivative Instruments (Level 2)											Fair Value of Derivative Instruments (Level 2)
	Asset Derivatives						Liability Derivatives					Asset Derivatives						Liability Derivatives
	Balance Sheet		Fair Value				Balance Sheet		Fair Value			Balance Sheet		Fair Value				Balance Sheet	Fair Value
	Location						Location					Location						Location
	(in thousands)
Derivatives designated as hedging instruments:
Foreign exchange forward contracts	Prepaid expense		$	3,059			Accrued		$	3,069		Prepaid expense		$	483			Accrued	$	805
	and other assets						liabilities					and other assets						liabilities
Derivatives not designated as hedging instruments:
Foreign exchange forward contracts	Prepaid expense			8			Accrued			515		Prepaid expense			1,109			Accrued		118
	and other assets						liabilities					and other assets						liabilities
Total derivatives			$	3,067					$	3,584				$	1,592				$	923
Under the master netting agreements with the respective counterparties to the Company’s foreign exchange contracts, subject to applicable requirements, the Company is allowed to net settle transactions of the same currency with a single net amount payable by one party to the other. However, the Company has elected to present the derivative assets and derivative liabilities on a gross basis in its balance sheet. As of September 28, 2014, the potential effect of netting the above foreign exchange contracts would be an offset to assets and liabilities by $1.7 million, resulting in a net derivative asset of $1.4 million and net derivative liabilities of $1.9 million. As of June 29, 2014, the potential effect of netting the above foreign exchange contracts was an offset to both assets and liabilities by $0.5 million, resulting in a net derivative asset of $1.1 million and net derivative liabilities of $0.5 million. The Company is not required to pledge, nor is the Company entitled to receive, cash collateral for these derivative transactions.
The effect of derivative instruments designated as cash flow hedges on the Company’s Condensed Consolidated Statements of Operations, including accumulated other comprehensive income (“AOCI”) was as follows:
	Three Months Ended September 28, 2014											Three Months Ended September 29, 2013
	Effective Portion								Ineffective Portion and			Effective Portion							Ineffective Portion and
									Amount Excluded from										Amount Excluded from
									Effectiveness Testing										Effectiveness Testing
Location of Gain (Loss) Recognized in or	Gain (Loss)				Gain (Loss)				Gain (Loss)			Gain (Loss)				Gain (Loss)			Gain (Loss)
Reclassified into Income	Recognized				Reclassified				Recognized			Recognized				Reclassified			Recognized
	in AOCI				from AOCI				in Income			in AOCI				from AOCI			in Income
					into Income											into Income
	(in thousands)											(in thousands)
Revenue	$	3,024			$	469			$	42		$	4,878			$	3,383		$	93
Cost of goods sold		(2,023	)			(276	)			(6	)		149				651			(32	)
Selling, general, and administrative		(866	)			(105	)			(1	)		48				317			(15	)
	$	135			$	88			$	35		$	5,075			$	4,351		$	46
The effect of derivative instruments not designated as cash flow hedges on the Company’s Condensed Consolidated Statements of Operations was as follows:
			Three Months Ended
			September 28,				September 29,
			2014				2013
Derivatives Not Designated	Location of Gain		Gain Recognized				Gain Recognized
as Hedging Instruments:	Recognized in Income		in Income				in Income
			(in thousands)
Foreign Exchange Contracts	Other income		$	968			$	6,027
Concentrations of Credit Risk
Financial instruments that potentially subject the Company to concentrations of credit risk consist principally of cash and cash equivalents, short-term investments, restricted cash and investments, trade accounts receivable, and derivative financial instruments used in hedging activities. Cash is placed on deposit at large global financial institutions. Such deposits may be in excess of insured limits. Management believes that the financial institutions that hold the Company’s cash are creditworthy and, accordingly, minimal credit risk exists with respect to these balances.
The Company’s overall portfolio of available-for-sale securities must maintain an average minimum rating of “AA-” or “Aa3” as rated by Standard and Poor’s or Moody’s Investor Services, respectively. To ensure diversification and minimize concentration, the Company’s policy limits the amount of credit exposure with any one financial institution or commercial issuer.
The Company is exposed to credit losses in the event of nonperformance by counterparties on the foreign currency forward hedge contracts and on structured share repurchase arrangements. These counterparties are large global financial institutions and, to date, no such counterparty has failed to meet its financial obligations to the Company.
Credit risk evaluations, including trade references, bank references and Dun & Bradstreet ratings, are performed on all new customers and the Company monitors its customers’ financial condition and payment performance. In general, the Company does not require collateral on sales.

INVENTORIES

INVENTORIES	3 Months Ended
	Sep. 28, 2014
INVENTORIES	'
	NOTE 5 — INVENTORIES
	Inventories are stated at the lower of cost (first-in, first-out method) or market. System shipments to Japanese customers, for which title does not transfer until customer acceptance, are classified as finished goods inventory and carried at cost until title transfers. Inventories consist of the following:
		September 28,		June 29,
		2014		2014
		(in thousands)
	Raw materials	$	497,058	$	449,623
	Work-in-process		121,804		126,564
	Finished goods		196,750		164,316
		$	815,612	$	740,503

GOODWILL_AND_INTANGIBLE_ASSETS

GOODWILL AND INTANGIBLE ASSETS	3 Months Ended
	Sep. 28, 2014
GOODWILL AND INTANGIBLE ASSETS	'
	NOTE 6 — GOODWILL AND INTANGIBLE ASSETS
	Goodwill
	There were no significant changes in the goodwill balance during the three months ended September 28, 2014. Of the $1.5 billion goodwill balance, $61 million is tax deductible and the remaining balance is not tax deductible due to purchase accounting and applicable foreign law.
	Intangible Assets
	The following table provides the Company’s intangible assets as of September 28, 2014:
		Gross		Accumulated			Net
				Amortization
		(in thousands)
	Customer relationships	$	615,549	$	(185,615	)	$	429,934
	Existing technology		643,779		(246,484	)		397,295
	Patents		32,053		(24,925	)		7,128
	Other intangible assets		35,670		(35,293	)		377
	Intangible assets subject to amortization		1,327,051		(492,317	)		834,734
	In process research and development		11,000					11,000
	Development rights		9,100					9,100
	Intangible assets not subject to amortization		20,100					20,100
	Total intangible assets	$	1,347,151	$	(492,317	)	$	854,834
	The following table provides the Company’s intangible assets as of June 29, 2014:
		Gross		Accumulated			Net
				Amortization
		(in thousands)
	Customer relationships	$	615,618	$	(169,162	)	$	446,456
	Existing technology		643,922		(224,246	)		419,676
	Patents		32,253		(24,407	)		7,846
	Other intangible assets		35,270		(35,270	)		—
	Intangible assets subject to amortization		1,327,063		(453,085	)		873,978
	In process research and development		11,000					11,000
	Development rights		9,100					9,100
	Intangible assets not subject to amortization		20,100					20,100
	Total intangible assets	$	1,347,163	$	(453,085	)	$	894,078
	The Company recognized $39.2 million and $41.6 million in intangible asset amortization expense during the three months ended September 28, 2014, and September 29, 2013, respectively.
	The estimated future amortization expense of intangible assets, excluding those with indefinite lives, as of September 28, 2014 was as follows:
	Fiscal Year	Amount
	2015 (9 Months)	$	117,482
	2016		154,130
	2017		152,427
	2018		151,215
	2019		120,285
	Thereafter		139,195
		$	834,734

ACCRUED_EXPENSES_AND_OTHER_CUR

ACCRUED EXPENSES AND OTHER CURRENT LIABILITIES	3 Months Ended
	Sep. 28, 2014
ACCRUED EXPENSES AND OTHER CURRENT LIABILITIES	'
	NOTE 7 — ACCRUED EXPENSES AND OTHER CURRENT LIABILITIES
	Accrued expenses and other current liabilities consist of the following:
		September 28,		June 29,
		2014		2014
		(in thousands)
	Accrued compensation	$	318,330	$	311,054
	Warranty reserves		70,185		68,324
	Income and other taxes payable		45,452		93,934
	Dividend payable		29,381		29,240
	Other		115,620		101,744
		$	578,968	$	604,296

OTHER_EXPENSE_NET

OTHER EXPENSE, NET	3 Months Ended
	Sep. 28, 2014
OTHER EXPENSE, NET	'
	NOTE 8 — OTHER EXPENSE, NET
	The significant components of other expense, net, are as follows:
		Three Months Ended
		September 28,			September 29,
		2014			2013
		(in thousands)
	Interest income	$	3,288		$	2,723
	Interest expense		(15,704	)		(15,302	)
	Gains on deferred compensation plan related assets		2,416			37
	Foreign exchange gains (losses)		906			(222	)
	Other, net		3,446			(1,498	)
		$	(5,648	)	$	(14,262	)
	During the three months ended September 28, 2014, the Company sold all of Peter Wolters, a wholly owned subsidiary acquired as part of the Novellus acquisition. Net pre-tax gain of $7.3 million associated with this divestiture is included in other expense, net in the Condensed Consolidated Statements of Operations.

INCOME_TAX_EXPENSE

INCOME TAX EXPENSE	3 Months Ended
	Sep. 28, 2014
INCOME TAX EXPENSE	'
	NOTE 9 — INCOME TAX EXPENSE
	The Company recorded an income tax expense of $21.6 million, which yielded an effective tax rate for the quarter ended September 28, 2014 of approximately 13.3%. The difference between the U.S. federal statutory tax rate of 35% and the Company’s effective tax rate for the quarter ended September 28, 2014 is primarily due to the geographic mix of income and the treatment of discrete items in determining the effective tax rate, offset by the tax effect of non-deductible stock-based compensation and unrecognized tax benefits due to uncertain tax positions.

NET_INCOME_PER_SHARE

NET INCOME PER SHARE	3 Months Ended
	Sep. 28, 2014
NET INCOME PER SHARE	'
	NOTE 10 — NET INCOME PER SHARE
	Basic net income per share is computed by dividing net income by the weighted-average number of shares of Common Stock outstanding during the period. Diluted net income per share is computed using the treasury stock method, for dilutive stock options, RSUs, and convertible notes. Dilutive shares outstanding include the effect of the 2016, 2018 and 2041 Notes. The following table reconciles the numerators and denominators of the basic and diluted computations for net income per share.
		Three Months Ended
		September 28,		September 29,
		2014		2013
		(in thousands, except per share data)
	Numerator:
	Net income	$	141,081	$	85,506
	Denominator:
	Basic average shares outstanding		161,685		162,896
	Effect of potential dilutive securities:
	Employee stock plans		3,560		2,868
	Convertible notes		11,867		5,599
	Warrants		6		—
	Diluted average shares outstanding		177,118		171,363
	Net income per share — basic	$	0.87	$	0.52
	Net income per share — diluted	$	0.8	$	0.5
	For purposes of computing diluted net income per share, weighted-average common shares do not include potentially dilutive securities that are anti-dilutive under the treasury stock method. The following potentially dilutive securities were excluded:
		Three Months Ended
		September 28,		September 29,
		2014		2013
		(in thousands)
	Number of potential dilutive securities excluded		—		290
	Diluted shares outstanding do not include any effect resulting from the note hedges associated with the Company’s 2016 or 2018 Notes (as described in Note 12) as their impact would have been anti-dilutive.

ACCUMULATED_OTHER_COMPREHENSIV

ACCUMULATED OTHER COMPREHENSIVE LOSS	3 Months Ended
	Sep. 28, 2014
ACCUMULATED OTHER COMPREHENSIVE LOSS	'
	NOTE 11 — ACCUMULATED OTHER COMPREHENSIVE LOSS
	The components of accumulated other comprehensive income (loss), net of tax at the end of the period, as well as the activity during the period, were as follows:
			Accumulated			Accumulated			Accumulated			Accumulated			Total
			foreign			unrealized			unrealized			unrealized
			currency			holding gain			holding gain			components
			translation			(loss) on cash			(loss) on			of defined
			adjustment			flow hedges			available-			benefit plans
									for-sale
									investments
			(in thousands)
	Balance as of June 29, 2014		$	(12,986	)	$	(66	)	$	1,557		$	(17,160	)	$	(28,655	)
	Other comprehensive income before reclassifications			(5,564	)		298			(1,759	)		66			(6,959	)
	(Losses) gains reclassified from accumulated other comprehensive income to net income			(3,395	)		(102	)(1)		379	(2)		—			(3,118	)
	Net current-period other comprehensive income		$	(8,959	)	$	196		$	(1,380	)	$	66		$	(10,077	)
	Balance as of September 28, 2014		$	(21,945	)	$	130		$	177		$	(17,094	)	$	(38,732	)
	-1	Amount of after tax gain reclassified from accumulated other comprehensive income into net income located in revenue: $441 gain, cost of goods sold: $250 loss and selling, general and administrative expenses: $89 loss.
	-2	Amount of after tax gain reclassified from accumulated other comprehensive income into net income located in other expense, net

LONGTERM_DEBT_AND_OTHER_BORROW

LONG-TERM DEBT AND OTHER BORROWINGS	3 Months Ended
	Sep. 28, 2014
LONG-TERM DEBT AND OTHER BORROWINGS	'
	NOTE 12 — LONG-TERM DEBT AND OTHER BORROWINGS
	Convertible Senior Notes
	In May 2011, the Company issued and sold $450.0 million in aggregate principal amount of 0.50% Convertible Senior Notes due May 2016 (the “2016 Notes”) at par. At the same time, the Company issued and sold $450.0 million in aggregate principal amount of 1.25% Convertible Senior Notes due May 2018 (the “2018 Notes”) at par. The Company pays cash interest at an annual rate of 0.5% and 1.25%, respectively, on the 2016 Notes and the 2018 Notes, on a semi-annual basis on May 15 and November 15 of each year.
	In June 2012, with the acquisition of Novellus, the Company assumed $700.0 million in aggregate principal amount of 2.625% Convertible Senior Notes due May 2041 (the “2041 Notes,” and collectively with the 2016 Notes and the 2018 Notes, the “Notes”). The Company pays cash interest at an annual rate of 2.625%, on a semi-annual basis on May 15 and November 15 of each year. The 2041 Notes also have a contingent interest payment provision that may require the Company to pay additional interest based on certain thresholds, beginning with the semi-annual interest payment on May 15, 2021, and upon the occurrence of certain events, as outlined in the indenture governing the 2041 Notes. The maximum amount of the contingent interest will accrue at a rate of 2.1% per annum, excluding any potential impact from dividends deemed payable to holders of the 2041 Notes.
	The Company separately accounts for the liability and equity components of the Notes. The initial debt components of the 2016 Notes, the 2018 Notes, and the 2041 Notes were valued based on the present value of the future cash flows using the Company’s borrowing rate at the date of the issuance or assumption for similar debt instruments without the conversion feature; which equals the effective interest rate on the liability component disclosed in the following table, respectively.
	As of September 28, 2014 and June 29, 2014, the Notes consisted of the following:
			September 28, 2014									June 29, 2014
			2016 Notes			2018 Notes			2041 Notes (1)			2016 Notes		2018 Notes		2041 Notes (1)
			(in thousands, except years, percentages, conversion rate, and conversion price)
	Carrying value, long-term		$	423,481		$	391,011		$	—		$	419,561	$	387,338	$	—
	Carrying value, current portion			—			—			517,503			—		—		516,586
	Unamortized discount			26,519			58,989			182,432			30,439		62,662		183,349
	Principal amount		$	450,000		$	450,000		$	699,935		$	450,000	$	450,000	$	699,935
	Remaining amortization period (years)			1.6			3.6			26.7
	Effective interest rate on liability component			4.29	%		5.27	%		4.28	%
	Carrying amount of equity component, net of tax		$	76,230		$	104,895		$	328,109
	Fair Value of Notes (Level 1)		$	573,525		$	610,205		$	1,542,041
	Conversion rate (shares of common stock per $1,000 principal amount of notes)			15.9527			15.9527			28.6288
	Conversion price (per share of common stock)		$	62.69		$	62.69		$	34.93
	If-converted value in excess of par value		$	89,911		$	89,911		$	807,144
	-1	During the quarter-ended September 28, 2014 and June 29, 2014 the market value of the Common Stock was greater than or equal to 130% of the 2041 Note conversion price for 20 or more trading days of the 30 consecutive trading days preceding the quarter end. As a result, the 2041 Notes are convertible at the option of the holder. The carrying amount of the 2041 Notes was classified in current liabilities and the excess of the amount of cash payable, if converted, over the carrying amount of the 2041 Notes was classified as temporary equity in the Company’s Consolidated Balance Sheets as of September 28, 2014 and June 29, 2014. Upon closure of a conversion period, all 2041 Notes not converted will be reclassified back to noncurrent liabilities and the temporary equity is reclassified to permanent equity.
	The following table presents the amount of interest cost recognized relating to both the contractual interest coupon and amortization of the discount on the liability component of the Notes during the three months ended September 28, 2014 and September 29, 2013.
			Three Months Ended
			September 28,			September 29,
			2014			2013
			(in thousands)
	Contractual interest coupon		$	6,562		$	6,562
	Amortization of interest discount			8,509			8,122
	Amortization of issuance costs			591			591
	Total interest cost recognized		$	15,662		$	15,275
	Convertible Note Hedges and Warrants
	Concurrent with the issuance of the 2016 Notes and 2018 Notes, the Company sold warrants. At expiration, the Company may, at its option, elect to settle the warrants on a net share basis. As of September 28, 2014, the warrants had not been exercised and remained outstanding. The exercise price is adjusted for certain corporate events, including dividends on the Company’s Common Stock.
	In addition, counterparties agreed to sell to the Company shares of Common Stock equal to the number of shares issuable upon conversion of the 2016 Notes and 2018 Notes in full. The convertible note hedge transactions will be settled in net shares and will terminate upon the earlier of the maturity date or the first day none of the respective notes remain outstanding due to conversion or otherwise. Settlement of the convertible note hedge in net shares, based on the number of shares issued upon conversion of the Notes, on the expiration date would result in the Company receiving net shares equivalent to the number of shares issuable by the Company upon conversion of the 2016 Notes and 2018 Notes. The exercise price is adjusted for certain corporate events, including dividends on the Company’s Common Stock. The following table presents the details of the warrants and convertible note hedge arrangements as of September 28, 2014:
			2016 Notes			2016 Notes
			(shares in thousands)
	Warrants:
	Number of shares to be delivered upon exercise			7,179			7,179
	Exercise price		$	70.96		$	75.7
	Expiration date range			August 15 -			August 15 -
				October 21, 2016			October 23, 2018
	Convertible Note Hedge:
	Number of shares available from counterparties			7,179			7,179
	Exercise price		$	62.69		$	62.69
	Revolving Credit Facility
	On March 12, 2014 the Company entered into a $300 million revolving unsecured credit facility with a syndicate of lenders that matures on March 12, 2019. The facility includes an option for the Company to, subject to certain requirements, request an increase in the facility of up to an additional $200 million, for a potential total commitment of $500 million. Proceeds from the credit facility can be used for general corporate purposes.
	Interest on amounts borrowed under the credit facility is, at the Company’s option, based on (i) a base rate, defined as the greatest of (a) prime rate, (b) Federal Funds rate plus 0.5%, or (c) one-month LIBOR plus 1.0%, plus a spread of 0.0% to 0.5%, or (ii) LIBOR plus a spread of 0.9% to 1.5%, in each case as the applicable spread is determined based on the rating of the Company’s non-credit enhanced, senior unsecured long-term debt. Principal and any accrued and unpaid interest, is due and payable upon maturity. Additionally, the Company will pay the lenders a quarterly commitment fee that varies based on the Company’s rating described above. The credit facility contains certain restrictive covenants including maintaining a total consolidated indebtedness to consolidated capitalization ratio of no more than 0.5 to 1.0 and maintaining unrestricted or unencumbered cash and investments of no less than $1.0 billion. As of September 28, 2014, the Company had no borrowings outstanding under the credit facility and was in compliance with all financial covenants.

COMMITMENTS_AND_CONTINGENCIES

COMMITMENTS AND CONTINGENCIES	3 Months Ended
	Sep. 28, 2014
COMMITMENTS AND CONTINGENCIES	'
	NOTE 13 — COMMITMENTS AND CONTINGENCIES
	Operating Leases and Related Guarantees
	The Company leases certain of its administrative, research and development (“R&D”) and manufacturing facilities, regional sales/service offices and certain equipment under non-cancelable operating leases. Certain of the Company’s facility leases for buildings located at its Fremont, California headquarters and certain other facility leases provide the Company with options to extend the leases for additional periods or to purchase the facilities. Certain of the Company’s facility leases provide for periodic rent increases based on the general rate of inflation.
	The Company has operating leases regarding certain improved properties in Fremont and Livermore, California (the “Operating Leases”). The Company was required to maintain cash collateral in an aggregate of approximately $132.5 million in separate interest-bearing accounts, and marketable securities collateral in an aggregate of approximately $11.1 million as security for the Company’s obligations. These amounts are recorded as restricted cash and investments in the Company’s Consolidated Balance Sheet as of September 28, 2014.
	During the term of the Operating Leases and when the terms of the Operating Leases expire, the property subject to those Operating Leases may be remarketed. The Company has guaranteed to the lessor that each property will have a certain minimum residual value. The aggregate guarantee made by the Company under the Operating Leases is generally no more than approximately $191.2 million; however, under certain default circumstances, the guarantee with regard to an Operating Lease may be 100% of the lessor’s aggregate investment in the applicable property, which in no case will exceed $220.0 million, in the aggregate.
	The Company’s contractual cash obligations with respect to operating leases, excluding the residential value guarantee discussed above, as of September 28, 2014 were as follows:
		Operating
		Leases
		(in thousands)
	Payments due by period:
	One year	$	15,203
	Two years		13,528
	Three years		11,761
	Four years		5,241
	Five years		4,395
	Over five years		13,850
	Less: Sublease Income		(639	)
	Total	$	63,339
	Other Guarantees
	The Company has issued certain indemnifications to its lessors for taxes and general liability under some of its agreements. The Company has entered into certain insurance contracts that may limit its exposure to such indemnifications. As of September 28, 2014, the Company had not recorded any liability in connection with these indemnifications, as it does not believe, based on information available, that it is probable that any amounts will be paid under these guarantees.
	Generally, the Company indemnifies, under pre-determined conditions and limitations, its customers for infringement of third-party intellectual property rights by the Company’s products or services. The Company seeks to limit its liability for such indemnity to an amount not to exceed the sales price of the products or services subject to its indemnification obligations. The Company does not believe, based on information available, that it is probable that any material amounts will be paid under these guarantees.
	The Company provides guarantees and standby letters of credit to certain parties as required for certain transactions initiated during the ordinary course of business. As of September 28, 2014, the maximum potential amount of future payments that it could be required to make under these arrangements and letters of credit was $14.8 million. The Company does not believe, based on historical experience and information currently available, that it is probable that any amounts will be required to be paid.
	Warranties
	The Company provides standard warranties on its systems. The liability amount is based on actual historical warranty spending activity by type of system, customer, and geographic region, modified for any known differences such as the impact of system reliability improvements.
	Changes in the Company’s product warranty reserves were as follows:
		Three Months Ended
		September 28,			September 29,
		2014			2013
		(in thousands)
	Balance at beginning of period	$	69,385		$	58,078
	Warranties issued during the period		24,536			16,753
	Settlements made during the period		(24,068	)		(14,305	)
	Changes in liability for pre-existing warranties		599			(655	)
	Balance at end of period	$	70,452		$	59,871
	Legal proceedings
	The Company is either a defendant or plaintiff in various actions that have arisen from time to time in the normal course of business, including intellectual property claims. The Company accrues for a liability when it is both probable that a liability has been incurred and the amount of the loss can be reasonably estimated. Significant judgment is required in both the determination of probability and the determination as to whether a loss is reasonably estimable. To the extent there is a reasonable possibility that the losses could exceed the amounts already accrued, the Company believes that the amount of any such additional loss would be immaterial to the Company’s business, financial condition, and results of operations.

STOCK_REPURCHASE_PROGRAM

STOCK REPURCHASE PROGRAM	3 Months Ended
	Sep. 28, 2014
STOCK REPURCHASE PROGRAM	'
	NOTE 14 — STOCK REPURCHASE PROGRAM
	On April 29, 2014, the Board of Directors authorized the repurchase of up to $850 million of Common Stock, which includes the remaining value available under the Company’s prior authorization. These repurchases can be conducted on the open market or as private purchases and may include the use of derivative contracts with large financial institutions, in all cases subject to compliance with applicable law. Repurchases will be funded using the Company’s on-shore cash and on-shore cash generation. This repurchase program has no termination date and may be suspended or discontinued at any time.
	Repurchases under the repurchase program were as follows during the periods indicated:
	Period		Total Number of		Total Cost		Average Price		Amount Available
			Shares		of Repurchase		Paid Per Share*		Under Repurchase
			Repurchased						Program
			(in thousands, except per share data)
	Available balance as of June 29, 2014								$	830,895
	Quarter ended September 28, 2014			3,818	$	296,721	$	70.01	$	534,174
	*	Average price paid per share excludes accelerated share repurchases for which cost was incurred during the September 2014 quarter, but that did not settle until the December 2014 quarter. See Collared Accelerated Share Repurchase section below for details regarding average price associated with these transactions.
	In addition to shares repurchased under the Board-authorized repurchase program shown above, during the three months ended September 28, 2014, the Company acquired 120,575 shares at a total cost of $8.3 million, which the Company withheld through net share settlements to cover minimum tax withholding obligations upon the vesting of restricted stock unit awards granted under the Company’s equity compensation plans. The shares retained by the Company through these net share settlements are not a part of the Board-authorized repurchase program but instead are authorized under the Company’s equity compensation plans.
	As part of its share repurchase program, the Company may from time-to-time enter into structured share repurchase arrangements with financial institutions using general corporate funds. Such arrangements entered into or settled during the three months ended September 28, 2014 included the following:
	Collared Accelerated Share Repurchases
	During the three months ended September 28, 2014, the Company entered into a collared accelerated share repurchase (“ASR”) transaction under a master repurchase arrangement. Under the ASR, the Company made an up-front cash payment of $250 million, in exchange for an initial delivery of approximately 3.2 million shares of its Common Stock.
	The number of shares to ultimately be repurchased by the Company is based generally on the volume-weighted average price (“VWAP”) of the Common Stock during the term of the ASR minus a pre-determined discount set at inception of the ASR, subject to collar provisions that provided a minimum and maximum number of shares that the Company could repurchase under the agreements. The minimum and maximum thresholds for the transaction were established based on the average of the VWAP prices for the Common Stock during an initial hedge period. The ASR was scheduled to end at any time on or after October 8, 2014 and on or before December 8, 2014. At the conclusion of the ASR, the Company could potentially receive additional shares based on the VWAP of the Common Stock during the term of the agreement minus the pre-determined fixed discount.
	The counterparty designated October 9, 2014 as the termination date, at which time the Company settled the ASR. Approximately 0.3 million shares were received at final settlement, which represented a weighted-average share price of approximately $72.90 for the transaction period.
	The Company accounted for the ASR as two separate transactions: (a) as shares of Common Stock acquired in a treasury stock transaction recorded on the acquisition date and (b) as a forward contract indexed to the Company’s own Common Stock and classified in stockholders’ equity. As such, the Company accounted for the shares that it received under the ASR as a repurchase of its Common Stock for the purpose of calculating earnings per common share. The Company has determined that the forward contract indexed to the Common Stock met all of the applicable criteria for equity classification in accordance with the Derivatives and Hedging topic of the FASB Accounting Standards Codification, and, therefore, the ASR was not accounted for as a derivative instrument. As of September 28, 2014, the aggregate repurchase price of $250 million was reflected as Treasury stock, at cost, in the Consolidated Balance Sheet.

EQUITYBASED_COMPENSATION_PLANS1

EQUITY-BASED COMPENSATION PLANS (Tables)	3 Months Ended
	Sep. 28, 2014
Recognized Equity Based Compensation Expense and Related Income Tax Benefit	'
	The Company recognized the following equity-based compensation expense and related income tax benefit in the Condensed Consolidated Statements of Operations:
		Three Months Ended
		September 28,			September 29,
		2014			2013
		(in millions)
	Equity-based compensation expense	$	32		$	23.2
	Income tax benefit related to equity-based compensation expense	$	4.7		$	3.9
Summary of Stock Plan Activity	'
	A summary of stock plan transactions is as follows:
		Options Outstanding						Restricted Stock Units
								Outstanding
		Number of			Weighted-			Number of			Weighted-
		Shares			Average			Shares			Average
					Exercise						Fair
					Price						Market
											Value at
											Grant
	29-Jun-14		1,331,886		$	32.2			5,635,469		$	45.83
	Granted		—		$	—			67,439		$	65.92
	Exercised		(165,696	)	$	27.81			N/A			N/A
	Cancelled		(7,452	)	$	29.86			(57,295	)	$	44.54
	Vested restricted stock		N/A			N/A			(387,148	)	$	41.9
	28-Sep-14		1,158,738		$	32.84			5,258,465		$	46.39
Schedule of ESPP Weighted-Average Assumptions	'
	Purchase rights under the 1999 ESPP were valued using the Black-Scholes option valuation model and the following weighted-average assumptions for the three months ended September 28, 2014 and September 29, 2013:
		Three Months Ended
		September 28,			September 29,
		2014			2013
	Expected term (years)		0.68			0.66
	Expected stock price volatility		29.07	%		31.43	%
	Risk-free interest rate		0.07	%		0.11	%
	Dividend Yield		0.29	%		—

FINANCIAL_INSTRUMENTS_Tables

FINANCIAL INSTRUMENTS (Tables)	3 Months Ended
	Sep. 28, 2014
Cash, Cash Equivalents, Short-Term Investments, Restricted Cash and Investments and Other Assets Measured at Fair Value on Recurring Basis	'
	The following table sets forth the Company’s cash, cash equivalents, short-term investments, restricted cash and investments, and other assets measured at fair value on a recurring basis at September 28, 2014 and June 29, 2014:
		September 28, 2014
		Cost				Unrealized				Unrealized			Fair Value				(Reported Within)
						Gain				(Loss)							Cash and Cash			Short-Term			Restricted		Other
																	Equivalents			Investments			Cash &		Assets
																							Investments
		(in thousands)
	Cash	$	286,534			$	—			$	—		$	286,534			$	280,665		$	—		$	5,869		—
	Level 1:
	Time Deposit		132,549				—				—			132,549				—			—			132,549		—
	Money Market Funds		1,013,013				—				—			1,013,013				1,013,013			—			—		—
	US Treasury and Agencies		241,522				178				(98	)		241,602				—			230,537			11,065		—
	Mutual Funds		20,071				3,635				—			23,706				—			—			—		23,706
	Level 1 Total	$	1,407,155			$	3,813			$	(98	)	$	1,410,870			$	1,013,013		$	230,537		$	143,614	$	23,706
	Level 2:
	Municipal Notes and Bonds		252,846				794				(12	)		253,628				—			253,628			—		—
	Government-Sponsored Enterprises		54,449				39				(68	)		54,420				—			54,420			—		—
	Foreign Government Bonds		34,192				26				(46	)		34,172				—			34,172			—		—
	Corporate Notes and Bonds		888,871				1,194				(1,099	)		888,966				—			888,966			—		—
	Mortgage Backed Securities — Residential		24,288				76				(152	)		24,212				—			24,212			—		—
	Mortgage Backed Securities — Commercial		108,165				117				(549	)		107,733				—			107,733			—		—
	Level 2 Total	$	1,362,811			$	2,246			$	(1,926	)	$	1,363,131			$	—		$	1,363,131		$	—	$	—
	Total	$	3,056,500			$	6,059			$	(2,024	)	$	3,060,535			$	1,293,678		$	1,593,668		$	149,483	$	23,706
		June 29, 2014
		Cost				Unrealized				Unrealized			Fair Value				(Reported Within)
						Gain				(Loss)							Cash and Cash			Short-Term			Restricted		Other
																	Equivalents			Investments			Cash &		Assets
																							Investments
		(in thousands)
	Cash	$	285,031			$	—			$	—		$	285,031			$	279,126		$	—		$	5,905		—
	Level 1:
	Time Deposit		132,549				—				—			132,549				—			—			132,549		—
	Money Market Funds		1,168,261				—				—			1,168,261				1,168,261			—			—		—
	US Treasury and Agencies		212,436				178				(27	)		212,587				—			204,549			8,038		—
	Mutual Funds		18,784				2,974				—			21,758				—			—			—		21,758
	Level 1 Total	$	1,532,030			$	3,152			$	(27	)	$	1,535,155			$	1,168,261		$	204,549		$	140,587	$	21,758
	Level 2:
	Municipal Notes and Bonds		334,329				1,108				(4	)		335,433				5,290			330,143			—		—
	Government-Sponsored Enterprises		27,666				41				(15	)		27,692				—			27,692			—		—
	Foreign Government Bonds		35,438				57				(28	)		35,467				—			35,467			—		—
	Corporate Notes and Bonds		874,540				2,034				(335	)		876,239				—			876,239			—		—
	Mortgage Backed Securities — Residential		27,067				59				(182	)		26,944				—			26,944			—		—
	Mortgage Backed Securities — Commercial		112,642				100				(809	)		111,933				—			111,933			—		—
	Level 2 Total	$	1,411,682			$	3,399			$	(1,373	)	$	1,413,708			$	5,290		$	1,408,418		$	—	$	—
	Total	$	3,228,743			$	6,551			$	(1,400	)	$	3,233,894			$	1,452,677		$	1,612,967		$	146,492	$	21,758
Schedule of Cash, Cash Equivalents, Short-Term Investments and Restricted Cash and Investments in Unrealized Loss Positions	'
	The following is an analysis of the Company’s cash, cash equivalents, short-term investments and restricted cash and investments in unrealized loss positions:
		September 28, 2014
		Unrealized Losses Less								Unrealized Losses							Total
		Than 12 Months								12 Months or Greater
		Fair Value				Gross				Fair			Gross				Fair Value			Gross
						Unrealized				Value			Unrealized							Unrealized
						Loss							Loss							Loss
		(in thousands)
	Municipal Notes and Bonds	$	13,717			$	(12	)		$	—		$	—			$	13,717		$	(12	)
	US Treasury & Agencies		58,326				(98	)			—			—				58,326			(98	)
	Government-Sponsored Enterprises		36,960				(68	)			—			—				36,960			(68	)
	Foreign Government Bonds		20,566				(46	)			—			—				20,566			(46	)
	Corporate Notes and Bonds		431,132				(1,072	)			3,525			(27	)			434,657			(1,099	)
	Mortgage Backed Securities — Residential		4,252				(83	)			4,487			(69	)			8,739			(152	)
	Mortgage Backed Securities — Commercial		69,068				(308	)			19,362			(241	)			88,430			(549	)
		$	634,021			$	(1,687	)		$	27,374		$	(337	)		$	661,395		$	(2,024	)
Schedule of Amortized Cost and Fair Value of Cash Equivalents, Short-Term Investments and Restricted Investments with Contractual Maturities	'
	The amortized cost and fair value of cash equivalents, short-term investments and restricted investments with contractual maturities are as follows as of September 28, 2014:
		Cost				Estimated
						Fair
						Value
		(in thousands)
	Due in one year or less	$	1,312,967			$	1,313,292
	Due after one year through five years		1,138,825				1,139,517
	Due in more than five years		298,103				297,486
		$	2,749,895			$	2,750,295
Schedule of Outstanding Foreign Currency Forward Contracts	'
	As of September 28, 2014, the Company had the following outstanding foreign currency forward contracts that were entered into under its cash flow and balance sheet hedge program:
		Derivatives Designated as								Derivatives Not Designated as
		Hedging Instruments:								Hedging Instruments:
		(in thousands)
	Foreign Currency Forward Contracts
		Buy Contracts				Sell Contracts				Buy Contracts			Sell Contracts
	Japanese Yen	$	—			$	58,868			$	—		$	21,379
	Swiss Franc		—				—				6,684			—
	Euro		59,270				—				22,430			—
	Korean Won		—				—				12,564			—
	Taiwan Dollar		—				—				33,487			—
		$	59,270			$	58,868			$	75,165		$	21,379
Schedule of Fair Value of Derivative Instruments	'
	The fair value of derivative instruments in the Company’s Consolidated Balance Sheets as of September 28, 2014 and June 29, 2014 were as follows:
		September 28, 2014											June 29, 2014
		Fair Value of Derivative Instruments (Level 2)											Fair Value of Derivative Instruments (Level 2)
		Asset Derivatives						Liability Derivatives					Asset Derivatives						Liability Derivatives
		Balance Sheet		Fair Value				Balance Sheet		Fair Value			Balance Sheet		Fair Value				Balance Sheet	Fair Value
		Location						Location					Location						Location
		(in thousands)
	Derivatives designated as hedging instruments:
	Foreign exchange forward contracts	Prepaid expense		$	3,059			Accrued		$	3,069		Prepaid expense		$	483			Accrued	$	805
		and other assets						liabilities					and other assets						liabilities
	Derivatives not designated as hedging instruments:
	Foreign exchange forward contracts	Prepaid expense			8			Accrued			515		Prepaid expense			1,109			Accrued		118
		and other assets						liabilities					and other assets						liabilities
	Total derivatives			$	3,067					$	3,584				$	1,592				$	923
Schedule of Derivative Instruments Designated as Cash Flow Hedges in Statements of Operations Including Accumulated Other Comprehensive Income	'
	The effect of derivative instruments designated as cash flow hedges on the Company’s Condensed Consolidated Statements of Operations, including accumulated other comprehensive income (“AOCI”) was as follows:
		Three Months Ended September 28, 2014											Three Months Ended September 29, 2013
		Effective Portion								Ineffective Portion and			Effective Portion							Ineffective Portion and
										Amount Excluded from										Amount Excluded from
										Effectiveness Testing										Effectiveness Testing
	Location of Gain (Loss) Recognized in or	Gain (Loss)				Gain (Loss)				Gain (Loss)			Gain (Loss)				Gain (Loss)			Gain (Loss)
	Reclassified into Income	Recognized				Reclassified				Recognized			Recognized				Reclassified			Recognized
		in AOCI				from AOCI				in Income			in AOCI				from AOCI			in Income
						into Income											into Income
		(in thousands)											(in thousands)
	Revenue	$	3,024			$	469			$	42		$	4,878			$	3,383		$	93
	Cost of goods sold		(2,023	)			(276	)			(6	)		149				651			(32	)
	Selling, general, and administrative		(866	)			(105	)			(1	)		48				317			(15	)
		$	135			$	88			$	35		$	5,075			$	4,351		$	46
	The effect of derivative instruments not designated as cash flow hedges on the Company’s Condensed Consolidated Statements of Operations was as follows:
				Three Months Ended
				September 28,				September 29,
				2014				2013
	Derivatives Not Designated	Location of Gain		Gain Recognized				Gain Recognized
	as Hedging Instruments:	Recognized in Income		in Income				in Income
				(in thousands)
	Foreign Exchange Contracts	Other income		$	968			$	6,027

INVENTORIES_Tables

INVENTORIES (Tables)	3 Months Ended
	Sep. 28, 2014
Schedule of Inventories	'
	Inventories consist of the following:
		September 28,		June 29,
		2014		2014
		(in thousands)
	Raw materials	$	497,058	$	449,623
	Work-in-process		121,804		126,564
	Finished goods		196,750		164,316
		$	815,612	$	740,503

GOODWILL_AND_INTANGIBLE_ASSETS1

GOODWILL AND INTANGIBLE ASSETS (Tables)	3 Months Ended
	Sep. 28, 2014
Schedule of Intangible Assets	'
	The following table provides the Company’s intangible assets as of September 28, 2014:
		Gross		Accumulated			Net
				Amortization
		(in thousands)
	Customer relationships	$	615,549	$	(185,615	)	$	429,934
	Existing technology		643,779		(246,484	)		397,295
	Patents		32,053		(24,925	)		7,128
	Other intangible assets		35,670		(35,293	)		377
	Intangible assets subject to amortization		1,327,051		(492,317	)		834,734
	In process research and development		11,000					11,000
	Development rights		9,100					9,100
	Intangible assets not subject to amortization		20,100					20,100
	Total intangible assets	$	1,347,151	$	(492,317	)	$	854,834
	The following table provides the Company’s intangible assets as of June 29, 2014:
		Gross		Accumulated			Net
				Amortization
		(in thousands)
	Customer relationships	$	615,618	$	(169,162	)	$	446,456
	Existing technology		643,922		(224,246	)		419,676
	Patents		32,253		(24,407	)		7,846
	Other intangible assets		35,270		(35,270	)		—
	Intangible assets subject to amortization		1,327,063		(453,085	)		873,978
	In process research and development		11,000					11,000
	Development rights		9,100					9,100
	Intangible assets not subject to amortization		20,100					20,100
	Total intangible assets	$	1,347,163	$	(453,085	)	$	894,078
Estimated Future Amortization Expense of Intangible Assets	'
	The estimated future amortization expense of intangible assets, excluding those with indefinite lives, as of September 28, 2014 was as follows:
	Fiscal Year	Amount
	2015 (9 Months)	$	117,482
	2016		154,130
	2017		152,427
	2018		151,215
	2019		120,285
	Thereafter		139,195
		$	834,734

ACCRUED_EXPENSES_AND_OTHER_CUR1

ACCRUED EXPENSES AND OTHER CURRENT LIABILITIES (Tables)	3 Months Ended
	Sep. 28, 2014
Schedule of Accrued Expenses and Other Current Liabilities	'
	Accrued expenses and other current liabilities consist of the following:
		September 28,		June 29,
		2014		2014
		(in thousands)
	Accrued compensation	$	318,330	$	311,054
	Warranty reserves		70,185		68,324
	Income and other taxes payable		45,452		93,934
	Dividend payable		29,381		29,240
	Other		115,620		101,744
		$	578,968	$	604,296

OTHER_EXPENSE_NET_Tables

OTHER EXPENSE, NET (Tables)	3 Months Ended
	Sep. 28, 2014
Components of Other Expense, Net	'
	The significant components of other expense, net, are as follows:
		Three Months Ended
		September 28,			September 29,
		2014			2013
		(in thousands)
	Interest income	$	3,288		$	2,723
	Interest expense		(15,704	)		(15,302	)
	Gains on deferred compensation plan related assets		2,416			37
	Foreign exchange gains (losses)		906			(222	)
	Other, net		3,446			(1,498	)
		$	(5,648	)	$	(14,262	)

NET_INCOME_PER_SHARE_Tables

NET INCOME PER SHARE (Tables)	3 Months Ended
	Sep. 28, 2014
Schedule of Numerators and Denominators of Basic and Diluted Computations for Net Income Per Share	'
	The following table reconciles the numerators and denominators of the basic and diluted computations for net income per share.
		Three Months Ended
		September 28,		September 29,
		2014		2013
		(in thousands, except per share data)
	Numerator:
	Net income	$	141,081	$	85,506
	Denominator:
	Basic average shares outstanding		161,685		162,896
	Effect of potential dilutive securities:
	Employee stock plans		3,560		2,868
	Convertible notes		11,867		5,599
	Warrants		6		—
	Diluted average shares outstanding		177,118		171,363
	Net income per share — basic	$	0.87	$	0.52
	Net income per share — diluted	$	0.8	$	0.5
Schedule of Potentially Dilutive Securities Excluded from EPS Calculations	'
	The following potentially dilutive securities were excluded:
		Three Months Ended
		September 28,		September 29,
		2014		2013
		(in thousands)
	Number of potential dilutive securities excluded		—		290

ACCUMULATED_OTHER_COMPREHENSIV1

ACCUMULATED OTHER COMPREHENSIVE LOSS (Tables)	3 Months Ended
	Sep. 28, 2014
Components of Accumulated Other Comprehensive Income or Loss	'
	The components of accumulated other comprehensive income (loss), net of tax at the end of the period, as well as the activity during the period, were as follows:
			Accumulated			Accumulated			Accumulated			Accumulated			Total
			foreign			unrealized			unrealized			unrealized
			currency			holding gain			holding gain			components
			translation			(loss) on cash			(loss) on			of defined
			adjustment			flow hedges			available-			benefit plans
									for-sale
									investments
			(in thousands)
	Balance as of June 29, 2014		$	(12,986	)	$	(66	)	$	1,557		$	(17,160	)	$	(28,655	)
	Other comprehensive income before reclassifications			(5,564	)		298			(1,759	)		66			(6,959	)
	(Losses) gains reclassified from accumulated other comprehensive income to net income			(3,395	)		(102	)(1)		379	(2)		—			(3,118	)
	Net current-period other comprehensive income		$	(8,959	)	$	196		$	(1,380	)	$	66		$	(10,077	)
	Balance as of September 28, 2014		$	(21,945	)	$	130		$	177		$	(17,094	)	$	(38,732	)
	-1	Amount of after tax gain reclassified from accumulated other comprehensive income into net income located in revenue: $441 gain, cost of goods sold: $250 loss and selling, general and administrative expenses: $89 loss.
	-2	Amount of after tax gain reclassified from accumulated other comprehensive income into net income located in other expense, net

LONGTERM_DEBT_AND_OTHER_BORROW1

LONG-TERM DEBT AND OTHER BORROWINGS (Tables)	3 Months Ended
	Sep. 28, 2014
Components of Notes	'
	As of September 28, 2014 and June 29, 2014, the Notes consisted of the following:
			September 28, 2014									June 29, 2014
			2016 Notes			2018 Notes			2041 Notes (1)			2016 Notes		2018 Notes		2041 Notes (1)
			(in thousands, except years, percentages, conversion rate, and conversion price)
	Carrying value, long-term		$	423,481		$	391,011		$	—		$	419,561	$	387,338	$	—
	Carrying value, current portion			—			—			517,503			—		—		516,586
	Unamortized discount			26,519			58,989			182,432			30,439		62,662		183,349
	Principal amount		$	450,000		$	450,000		$	699,935		$	450,000	$	450,000	$	699,935
	Remaining amortization period (years)			1.6			3.6			26.7
	Effective interest rate on liability component			4.29	%		5.27	%		4.28	%
	Carrying amount of equity component, net of tax		$	76,230		$	104,895		$	328,109
	Fair Value of Notes (Level 1)		$	573,525		$	610,205		$	1,542,041
	Conversion rate (shares of common stock per $1,000 principal amount of notes)			15.9527			15.9527			28.6288
	Conversion price (per share of common stock)		$	62.69		$	62.69		$	34.93
	If-converted value in excess of par value		$	89,911		$	89,911		$	807,144
	-1	During the quarter-ended September 28, 2014 and June 29, 2014 the market value of the Common Stock was greater than or equal to 130% of the 2041 Note conversion price for 20 or more trading days of the 30 consecutive trading days preceding the quarter end. As a result, the 2041 Notes are convertible at the option of the holder. The carrying amount of the 2041 Notes was classified in current liabilities and the excess of the amount of cash payable, if converted, over the carrying amount of the 2041 Notes was classified as temporary equity in the Company’s Consolidated Balance Sheets as of September 28, 2014 and June 29, 2014. Upon closure of a conversion period, all 2041 Notes not converted will be reclassified back to noncurrent liabilities and the temporary equity is reclassified to permanent equity.
Schedule of Recognized Interest Cost Relating to Both Contractual Interest Coupon and Amortization of Discount on Liability Component of Notes	'
	The following table presents the amount of interest cost recognized relating to both the contractual interest coupon and amortization of the discount on the liability component of the Notes during the three months ended September 28, 2014 and September 29, 2013.
			Three Months Ended
			September 28,			September 29,
			2014			2013
			(in thousands)
	Contractual interest coupon		$	6,562		$	6,562
	Amortization of interest discount			8,509			8,122
	Amortization of issuance costs			591			591
	Total interest cost recognized		$	15,662		$	15,275
Warrants and Convertible Note Hedge Arrangements	'
	The following table presents the details of the warrants and convertible note hedge arrangements as of September 28, 2014:
			2016 Notes			2016 Notes
			(shares in thousands)
	Warrants:
	Number of shares to be delivered upon exercise			7,179			7,179
	Exercise price		$	70.96		$	75.7
	Expiration date range			August 15 -			August 15 -
				October 21, 2016			October 23, 2018
	Convertible Note Hedge:
	Number of shares available from counterparties			7,179			7,179
	Exercise price		$	62.69		$	62.69

COMMITMENTS_AND_CONTINGENCIES_

COMMITMENTS AND CONTINGENCIES (Tables)	3 Months Ended
	Sep. 28, 2014
Schedule of Contractual Cash Obligations Relating to Operating Leases	'
	The Company’s contractual cash obligations with respect to operating leases, excluding the residential value guarantee discussed above, as of September 28, 2014 were as follows:
		Operating
		Leases
		(in thousands)
	Payments due by period:
	One year	$	15,203
	Two years		13,528
	Three years		11,761
	Four years		5,241
	Five years		4,395
	Over five years		13,850
	Less: Sublease Income		(639	)
	Total	$	63,339
Schedule of Changes in Product Warranty Reserves	'
	Changes in the Company’s product warranty reserves were as follows:
		Three Months Ended
		September 28,			September 29,
		2014			2013
		(in thousands)
	Balance at beginning of period	$	69,385		$	58,078
	Warranties issued during the period		24,536			16,753
	Settlements made during the period		(24,068	)		(14,305	)
	Changes in liability for pre-existing warranties		599			(655	)
	Balance at end of period	$	70,452		$	59,871

STOCK_REPURCHASE_PROGRAM_Table

STOCK REPURCHASE PROGRAM (Tables)	3 Months Ended
	Sep. 28, 2014
Schedule of Repurchases under Repurchase Program	'
	Repurchases under the repurchase program were as follows during the periods indicated:
	Period		Total Number of		Total Cost		Average Price		Amount Available
			Shares		of Repurchase		Paid Per Share*		Under Repurchase
			Repurchased						Program
			(in thousands, except per share data)
	Available balance as of June 29, 2014								$	830,895
	Quarter ended September 28, 2014			3,818	$	296,721	$	70.01	$	534,174
	*	Average price paid per share excludes accelerated share repurchases for which cost was incurred during the September 2014 quarter, but that did not settle until the December 2014 quarter. See Collared Accelerated Share Repurchase section below for details regarding average price associated with these transactions.

Equity_Based_Compensation_Plan

Equity Based Compensation Plans - Additional Information (Detail) (USD $)	3 Months Ended
In Millions, unless otherwise specified	Sep. 28, 2014
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]	'
Options and restricted stock units vesting period, years	'3 years
Novellus Systems Incorporated	'
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]	'
Options and restricted stock units vesting period, years	'4 years
Employee Stock Purchase Plan	'
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]	'
Weighted average remaining period for recognition, years	'11 months
ESPP purchase price per share as percentage of fair market value	85.00%
Unrecognized compensation expense	13.2
Stock Options	'
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]	'
Unrecognized compensation expense, stock option	3.4
Weighted average remaining period for recognition, years	'1 year 6 months
Restricted Stock Units (RSUs)	'
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]	'
Weighted average remaining period for recognition, years	'1 year 9 months 18 days
Unrecognized compensation expense	154.2

Recognized_Equity_Based_Compen

Recognized Equity Based Compensation Expenses and Related Income Tax Benefit (Detail) (USD $)	3 Months Ended
In Millions, unless otherwise specified	Sep. 28, 2014	Sep. 29, 2013
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]	'	'
Equity-based compensation expense	$32	$23.20
Income tax benefit related to equity-based compensation expense	$4.70	$3.90

Summary_of_Stock_Plan_Activity

Summary of Stock Plan Activity (Detail) (USD $)	3 Months Ended
	Sep. 28, 2014
Options Outstanding Number of Shares	'
Beginning balance	1,331,886
Granted	'
Exercised	-165,696
Cancelled	-7,452
Ending balance	1,158,738
Weighted-Average Exercise Price	'
Beginning balance	$32.20
Granted	'
Exercised	$27.81
Cancelled	$29.86
Ending balance	$32.84
Restricted stock units outstanding number of shares	'
Beginning balance	5,635,469
Granted	67,439
Cancelled	-57,295
Vested restricted stock	-387,148
Ending balance	5,258,465
Restricted Stock Units Outstanding Number of Shares Weighted-Average FMV at Grant	'
Beginning balance	$45.83
Granted	$65.92
Cancelled	$44.54
Vested restricted stock	$41.90
Ending balance	$46.39

Schedule_of_Stock_Options_Weig

Schedule of Stock Options Weighted Average Assumptions (Detail) (Employee Stock Purchase Plan)	3 Months Ended
	Sep. 28, 2014	Sep. 29, 2013
Employee Stock Purchase Plan	'	'
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]	'	'
Expected term (years)	'8 months 5 days	'7 months 28 days
Expected stock price volatility	29.07%	31.43%
Risk-free interest rate	0.07%	0.11%
Dividend Yield	0.29%	'

Cash_Cash_Equivalents_ShortTer

Cash, Cash Equivalents, Short-Term Investments, Restricted Cash and Investments and Other Assets Measured at Fair Value on Recurring Basis (Detail) (USD $)	Sep. 28, 2014	Jun. 29, 2014
In Thousands, unless otherwise specified
Financial Instruments [Line Items]	'	'
Cost	$3,056,500	$3,228,743
Unrealized Gain	6,059	6,551
Unrealized (Loss)	-2,024	-1,400
Estimated Fair Value	3,060,535	3,233,894
Cash and Cash Equivalents	1,293,678	1,452,677
Short-Term Investments	1,593,668	1,612,967
Restricted Cash & Investments	149,483	146,492
Other Assets	23,706	21,758
Fair Value Level 1	'	'
Financial Instruments [Line Items]	'	'
Cost	1,407,155	1,532,030
Unrealized Gain	3,813	3,152
Unrealized (Loss)	-98	-27
Estimated Fair Value	1,410,870	1,535,155
Cash and Cash Equivalents	1,013,013	1,168,261
Short-Term Investments	230,537	204,549
Restricted Cash & Investments	143,614	140,587
Other Assets	23,706	21,758
Fair Value Level 2	'	'
Financial Instruments [Line Items]	'	'
Cost	1,362,811	1,411,682
Unrealized Gain	2,246	3,399
Unrealized (Loss)	-1,926	-1,373
Estimated Fair Value	1,363,131	1,413,708
Cash and Cash Equivalents	'	5,290
Short-Term Investments	1,363,131	1,408,418
Fair Value Level 2 | Municipal Notes And Bonds	'	'
Financial Instruments [Line Items]	'	'
Cost	252,846	334,329
Unrealized Gain	794	1,108
Unrealized (Loss)	-12	-4
Estimated Fair Value	253,628	335,433
Cash and Cash Equivalents	'	5,290
Short-Term Investments	253,628	330,143
Fair Value Level 2 | Corporate Notes And Bonds	'	'
Financial Instruments [Line Items]	'	'
Cost	888,871	874,540
Unrealized Gain	1,194	2,034
Unrealized (Loss)	-1,099	-335
Estimated Fair Value	888,966	876,239
Short-Term Investments	888,966	876,239
Cash	'	'
Financial Instruments [Line Items]	'	'
Cost	286,534	285,031
Estimated Fair Value	286,534	285,031
Cash and Cash Equivalents	280,665	279,126
Restricted Cash & Investments	5,869	5,905
Time Deposits | Fair Value Level 1	'	'
Financial Instruments [Line Items]	'	'
Cost	132,549	132,549
Estimated Fair Value	132,549	132,549
Restricted Cash & Investments	132,549	132,549
Money Market Funds | Fair Value Level 1	'	'
Financial Instruments [Line Items]	'	'
Cost	1,013,013	1,168,261
Estimated Fair Value	1,013,013	1,168,261
Cash and Cash Equivalents	1,013,013	1,168,261
US Treasury and Agencies | Fair Value Level 1	'	'
Financial Instruments [Line Items]	'	'
Cost	241,522	212,436
Unrealized Gain	178	178
Unrealized (Loss)	-98	-27
Estimated Fair Value	241,602	212,587
Short-Term Investments	230,537	204,549
Restricted Cash & Investments	11,065	8,038
Mutual Funds | Fair Value Level 1	'	'
Financial Instruments [Line Items]	'	'
Cost	20,071	18,784
Unrealized Gain	3,635	2,974
Estimated Fair Value	23,706	21,758
Other Assets	23,706	21,758
Government-Sponsored Enterprises | Fair Value Level 2	'	'
Financial Instruments [Line Items]	'	'
Cost	54,449	27,666
Unrealized Gain	39	41
Unrealized (Loss)	-68	-15
Estimated Fair Value	54,420	27,692
Short-Term Investments	54,420	27,692
Foreign Government Bonds | Fair Value Level 2	'	'
Financial Instruments [Line Items]	'	'
Cost	34,192	35,438
Unrealized Gain	26	57
Unrealized (Loss)	-46	-28
Estimated Fair Value	34,172	35,467
Short-Term Investments	34,172	35,467
Mortgage Backed Securities - Residential | Fair Value Level 2	'	'
Financial Instruments [Line Items]	'	'
Cost	24,288	27,067
Unrealized Gain	76	59
Unrealized (Loss)	-152	-182
Estimated Fair Value	24,212	26,944
Short-Term Investments	24,212	26,944
Mortgage Backed Securities - Commercial | Fair Value Level 2	'	'
Financial Instruments [Line Items]	'	'
Cost	108,165	112,642
Unrealized Gain	117	100
Unrealized (Loss)	-549	-809
Estimated Fair Value	107,733	111,933
Short-Term Investments	$107,733	$111,933

Financial_Instruments_Addition

Financial Instruments - Additional Information (Detail) (USD $)	3 Months Ended				3 Months Ended
	Sep. 28, 2014	Sep. 29, 2013	Sep. 28, 2014	Jun. 29, 2014	Sep. 28, 2014	Sep. 28, 2014
			Foreign Exchange Forward Contracts	Foreign Exchange Forward Contracts	Maximum	Maximum
			Cash flow hedging	Cash flow hedging		Majority of Contracts
Financial Instruments [Line Items]	'	'	'	'	'	'
Other than temporary impairment included in net realized gains (losses)	$0	$0	'	'	'	'
Gains realized from sales of investments	500,000	200,000	'	'	'	'
Losses realized from sales of investments	-600,000	-600,000	'	'	'	'
Investment classified as short term, contractual maturity period	'1 year	'	'	'	'	'
Foreign currency forward contract, expiration period	'	'	'	'	'24 months	'12 months
Gains (losses) accumulated in other comprehensive income expects to reclassify from other comprehensive income into earnings	100,000	'	'	'	'	'
Potential effect of rights of set-off under master netting agreements for foreign exchange contracts assets	'	'	1,700,000	500,000	'	'
Potential effect of rights of set-off under master netting agreements for foreign exchange contracts liabilities	'	'	1,700,000	500,000	'	'
Net derivative asset from master netting agreements	'	'	1,400,000	1,100,000	'	'
Net derivative liabilities from master netting agreements	'	'	$1,900,000	$500,000	'	'

Schedule_of_Cash_Cash_Equivale

Schedule of Cash, Cash Equivalents, Short-Term Investments and Restricted Cash and Investments Unrealized Loss Positions (Detail) (USD $)	Sep. 28, 2014
In Thousands, unless otherwise specified
Schedule of Available-for-sale Securities [Line Items]	'
Unrealized Losses Less Than 12 Months - Fair Value	$634,021
Unrealized Losses Less Than 12 Months - Gross Unrealized Loss	-1,687
Unrealized Losses 12 Months or Greater - Fair Value	27,374
Unrealized Losses 12 Months or Greater - Gross Unrealized Loss	-337
Total - Fair Value	661,395
Total - Gross Unrealized Loss	-2,024
Municipal Notes And Bonds	'
Schedule of Available-for-sale Securities [Line Items]	'
Unrealized Losses Less Than 12 Months - Fair Value	13,717
Unrealized Losses Less Than 12 Months - Gross Unrealized Loss	-12
Total - Fair Value	13,717
Total - Gross Unrealized Loss	-12
Corporate Notes And Bonds	'
Schedule of Available-for-sale Securities [Line Items]	'
Unrealized Losses Less Than 12 Months - Fair Value	431,132
Unrealized Losses Less Than 12 Months - Gross Unrealized Loss	-1,072
Unrealized Losses 12 Months or Greater - Fair Value	3,525
Unrealized Losses 12 Months or Greater - Gross Unrealized Loss	-27
Total - Fair Value	434,657
Total - Gross Unrealized Loss	-1,099
US Treasury and Agencies	'
Schedule of Available-for-sale Securities [Line Items]	'
Unrealized Losses Less Than 12 Months - Fair Value	58,326
Unrealized Losses Less Than 12 Months - Gross Unrealized Loss	-98
Total - Fair Value	58,326
Total - Gross Unrealized Loss	-98
Government-Sponsored Enterprises	'
Schedule of Available-for-sale Securities [Line Items]	'
Unrealized Losses Less Than 12 Months - Fair Value	36,960
Unrealized Losses Less Than 12 Months - Gross Unrealized Loss	-68
Total - Fair Value	36,960
Total - Gross Unrealized Loss	-68
Foreign Government Bonds	'
Schedule of Available-for-sale Securities [Line Items]	'
Unrealized Losses Less Than 12 Months - Fair Value	20,566
Unrealized Losses Less Than 12 Months - Gross Unrealized Loss	-46
Total - Fair Value	20,566
Total - Gross Unrealized Loss	-46
Mortgage Backed Securities - Residential	'
Schedule of Available-for-sale Securities [Line Items]	'
Unrealized Losses Less Than 12 Months - Fair Value	4,252
Unrealized Losses Less Than 12 Months - Gross Unrealized Loss	-83
Unrealized Losses 12 Months or Greater - Fair Value	4,487
Unrealized Losses 12 Months or Greater - Gross Unrealized Loss	-69
Total - Fair Value	8,739
Total - Gross Unrealized Loss	-152
Mortgage Backed Securities - Commercial	'
Schedule of Available-for-sale Securities [Line Items]	'
Unrealized Losses Less Than 12 Months - Fair Value	69,068
Unrealized Losses Less Than 12 Months - Gross Unrealized Loss	-308
Unrealized Losses 12 Months or Greater - Fair Value	19,362
Unrealized Losses 12 Months or Greater - Gross Unrealized Loss	-241
Total - Fair Value	88,430
Total - Gross Unrealized Loss	($549)

Schedule_of_Amortized_Cost_and

Schedule of Amortized Cost and Fair Value of Cash Equivalents, Short-Term Investments and Restricted Investments with Contractual Maturities (Detail) (USD $)	Sep. 28, 2014	Jun. 29, 2014
In Thousands, unless otherwise specified
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]	'	'
Due in one year or less, cost	$1,312,967	'
Due after one year through five years, cost	1,138,825	'
Due in more than five years, cost	298,103	'
Cost	2,749,895	'
Due in one year or less, estimated fair value	1,313,292	'
Due after one year through five years, estimated fair value	1,139,517	'
Due in more than five years, estimated fair value	297,486	'
Estimated Fair Value	3,060,535	3,233,894
Total Short Term Investments	'	'
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]	'	'
Estimated Fair Value	$2,750,295	'

Schedule_of_Outstanding_Foreig

Schedule of Outstanding Foreign Currency Forward Contracts (Detail) (USD $)	Sep. 28, 2014
In Thousands, unless otherwise specified
Buy Contracts	'
Derivative [Line Items]	'
Derivatives Designated as Hedging Instruments	$59,270
Derivatives Not Designated as Hedging Instruments	75,165
Buy Contracts | Swiss Francs	'
Derivative [Line Items]	'
Derivatives Not Designated as Hedging Instruments	6,684
Buy Contracts | Euro	'
Derivative [Line Items]	'
Derivatives Designated as Hedging Instruments	59,270
Derivatives Not Designated as Hedging Instruments	22,430
Buy Contracts | Korea (South), Won	'
Derivative [Line Items]	'
Derivatives Not Designated as Hedging Instruments	12,564
Buy Contracts | Taiwan Dollar	'
Derivative [Line Items]	'
Derivatives Not Designated as Hedging Instruments	33,487
Sell Contracts	'
Derivative [Line Items]	'
Derivatives Designated as Hedging Instruments	58,868
Derivatives Not Designated as Hedging Instruments	21,379
Sell Contracts | Japanese Yen	'
Derivative [Line Items]	'
Derivatives Designated as Hedging Instruments	58,868
Derivatives Not Designated as Hedging Instruments	$21,379

Schedule_of_Fair_Value_of_Deri

Schedule of Fair Value of Derivative Instruments (Detail) (Foreign Exchange Forward Contracts, Fair Value Level 2, USD $)	Sep. 28, 2014	Jun. 29, 2014
In Thousands, unless otherwise specified
Accrued Liabilities	'	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'
Liability Derivatives, Fair Value	$3,584	$923
Derivatives Designated As Hedging Instruments | Accrued Liabilities	'	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'
Liability Derivatives, Fair Value	3,069	805
Derivatives Not Designated as Hedging Instruments | Accrued Liabilities	'	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'
Liability Derivatives, Fair Value	515	118
Prepaid Expenses and Other Current Assets	'	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'
Asset Derivatives, Fair Value	3,067	1,592
Prepaid Expenses and Other Current Assets | Derivatives Designated As Hedging Instruments	'	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'
Asset Derivatives, Fair Value	3,059	483
Prepaid Expenses and Other Current Assets | Derivatives Not Designated as Hedging Instruments	'	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'
Asset Derivatives, Fair Value	$8	$1,109

Schedule_of_Derivative_Instrum

Schedule of Derivative Instruments Designated as Cash Flow Hedges in Statements of Operations Including Accumulated Other Comprehensive Income (Detail) (USD $)	3 Months Ended
In Thousands, unless otherwise specified	Sep. 28, 2014	Sep. 29, 2013
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'
Gain (Loss) Recognized in AOCI (Effective Portion)	$135	$5,075
Gain (Loss) Reclassified from AOCI into Income (Effective Portion)	88	4,351
Gain (Loss) Recognized (Excluded from Effectiveness Testing)	35	46
Located in revenue	'	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'
Gain (Loss) Recognized in AOCI (Effective Portion)	3,024	4,878
Gain (Loss) Reclassified from AOCI into Income (Effective Portion)	469	3,383
Gain (Loss) Recognized (Excluded from Effectiveness Testing)	42	93
Cost of Sales	'	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'
Gain (Loss) Recognized in AOCI (Effective Portion)	-2,023	149
Gain (Loss) Reclassified from AOCI into Income (Effective Portion)	-276	651
Gain (Loss) Recognized (Excluded from Effectiveness Testing)	-6	-32
Located in selling, general, and administrative	'	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'
Gain (Loss) Recognized in AOCI (Effective Portion)	-866	48
Gain (Loss) Reclassified from AOCI into Income (Effective Portion)	-105	317
Gain (Loss) Recognized (Excluded from Effectiveness Testing)	-1	-15
Foreign Exchange Forward Contracts	'	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'
Gain (Loss) Recognized	$968	$6,027

Schedule_of_Inventories_Detail

Schedule of Inventories (Detail) (USD $)	Sep. 28, 2014	Jun. 29, 2014
In Thousands, unless otherwise specified
Inventory [Line Items]	'	'
Raw materials	$497,058	$449,623
Work-in-process	121,804	126,564
Finished goods	196,750	164,316
Total inventories	$815,612	$740,503	[1]
[1]	Derived from audited financial statements

Recovered_Sheet1

Goodwill and Intangible Assets - Additional Information (Detail) (USD $)	3 Months Ended
	Sep. 28, 2014	Sep. 29, 2013	Jun. 29, 2014
Goodwill And Intangible Assets [Line Items]	'	'	'
Goodwill	$1,467,319,000	'	$1,466,225,000	[1]
Tax deductible goodwill	61,000,000	'	'
Intangible asset amortization expense	$39,200,000	$41,600,000	'
[1]	Derived from audited financial statements

Schedule_of_Intangible_Assets_

Schedule of Intangible Assets (Detail) (USD $)	Sep. 28, 2014	Jun. 29, 2014
In Thousands, unless otherwise specified
Goodwill And Intangible Assets [Line Items]	'	'
Gross intangible assets subject to amortization	$1,327,051	$1,327,063
Total gross intangible assets	1,347,151	1,347,163
Accumulated Amortization	-492,317	-453,085
Net intangible assets subject to amortization	834,734	873,978
Intangible assets, net	854,834	894,078	[1]
Intangible assets not subject to amortization	20,100	20,100
Customer Relationships	'	'
Goodwill And Intangible Assets [Line Items]	'	'
Gross intangible assets subject to amortization	615,549	615,618
Accumulated Amortization	-185,615	-169,162
Net intangible assets subject to amortization	429,934	446,456
Existing Technology	'	'
Goodwill And Intangible Assets [Line Items]	'	'
Gross intangible assets subject to amortization	643,779	643,922
Accumulated Amortization	-246,484	-224,246
Net intangible assets subject to amortization	397,295	419,676
Patents	'	'
Goodwill And Intangible Assets [Line Items]	'	'
Gross intangible assets subject to amortization	32,053	32,253
Accumulated Amortization	-24,925	-24,407
Net intangible assets subject to amortization	7,128	7,846
Other Intangible Assets	'	'
Goodwill And Intangible Assets [Line Items]	'	'
Gross intangible assets subject to amortization	35,670	35,270
Accumulated Amortization	-35,293	-35,270
Net intangible assets subject to amortization	377	'
In Process Research And Development	'	'
Goodwill And Intangible Assets [Line Items]	'	'
Intangible assets not subject to amortization	11,000	11,000
Development Rights	'	'
Goodwill And Intangible Assets [Line Items]	'	'
Intangible assets not subject to amortization	$9,100	$9,100
[1]	Derived from audited financial statements

Estimated_Future_Amortization_

Estimated Future Amortization Expense of Intangible Assets (Detail) (USD $)	Sep. 28, 2014	Jun. 29, 2014
In Thousands, unless otherwise specified
Finite-Lived Intangible Assets [Line Items]	'	'
2015 (9 Months)	$117,482	'
2016	154,130	'
2017	152,427	'
2018	151,215	'
2019	120,285	'
Thereafter	139,195	'
Net intangible assets subject to amortization	$834,734	$873,978

Schedule_of_Accrued_Expenses_a

Schedule of Accrued Expenses and Other Current Liabilities (Detail) (USD $)	Sep. 28, 2014	Jun. 29, 2014
In Thousands, unless otherwise specified
Schedule of Accrued Liabilities [Line Items]	'	'
Accrued compensation	$318,330	$311,054
Warranty reserves	70,185	68,324
Income and other taxes payable	45,452	93,934
Dividend payable	29,381	29,240
Other	115,620	101,744
Accrued expenses and other current liabilities	$578,968	$604,296	[1]
[1]	Derived from audited financial statements

Components_of_Other_Expense_Ne

Components of Other Expense, Net (Detail) (USD $)	3 Months Ended
In Thousands, unless otherwise specified	Sep. 28, 2014	Sep. 29, 2013
Component Of Other Expense Income Nonoperating [Line Items]	'	'
Interest income	$3,288	$2,723
Interest expense	-15,704	-15,302
Gains on deferred compensation plan related assets	2,416	37
Foreign exchange gains (losses)	906	-222
Other, net	3,446	-1,498
Other income (expense), net	($5,648)	($14,262)

Components_of_Other_Expense_Ne1

Components of Other Expense, Net - Additional Information (Detail) (Novellus Systems Incorporated, USD $)	3 Months Ended
In Millions, unless otherwise specified	Sep. 28, 2014
Novellus Systems Incorporated	'
Component Of Other Expense Income Nonoperating [Line Items]	'
Net pre-tax gain associated with divestiture	$7.30

Income_Tax_Expense_Additional_

Income Tax Expense - Additional Information (Detail) (USD $)	3 Months Ended
In Thousands, unless otherwise specified	Sep. 28, 2014	Sep. 29, 2013
Income Tax [Line Items]	'	'
Income tax (benefit) expense	$21,569	$5,640
Effective income tax rate	13.30%	'
U.S. federal statutory tax rate	35.00%	'

Schedule_of_Numerators_and_Den

Schedule of Numerators and Denominators of Basic and Diluted Computations for Net Income Per Share (Detail) (USD $)	3 Months Ended
In Thousands, except Per Share data, unless otherwise specified	Sep. 28, 2014	Sep. 29, 2013
Schedule of Earnings Per Share, Basic and Diluted, by Common Class [Line Items]	'	'
Net income	$141,081	$85,506
Basic average shares outstanding	161,685	162,896
Employee stock plans	3,560	2,868
Convertible notes	11,867	5,599
Warrants	6	'
Diluted average shares outstanding	177,118	171,363
Net income per share - basic	$0.87	$0.52
Net income per share - diluted	$0.80	$0.50

Schedule_of_Potentially_Diluti

Schedule of Potentially Dilutive Securities Excluded from EPS Calculations (Detail)	3 Months Ended
In Thousands, unless otherwise specified	Sep. 29, 2013
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]	'
Number of potential dilutive securities excluded	290

Components_of_Accumulated_Othe

Components of Accumulated Other Comprehensive Loss (Detail) (USD $)	3 Months Ended
In Thousands, unless otherwise specified	Sep. 28, 2014		Sep. 29, 2013
Accumulated Other Comprehensive Income (Loss) [Line Items]	'		'
Balance as of June 29, 2014	($28,655)	[1]	'
Other comprehensive income before reclassifications	-6,959		'
(Losses) gains reclassified from accumulated other comprehensive income to net income	-3,118		'
Net current-period other comprehensive (loss) income	-10,077		5,338
Balance as of September 28, 2014	-38,732		'
Accumulated Foreign Currency Translation Adjustment	'		'
Accumulated Other Comprehensive Income (Loss) [Line Items]	'		'
Balance as of June 29, 2014	-12,986		'
Other comprehensive income before reclassifications	-5,564		'
(Losses) gains reclassified from accumulated other comprehensive income to net income	-3,395		'
Net current-period other comprehensive (loss) income	-8,959		'
Balance as of September 28, 2014	-21,945		'
Accumulated Unrealized Holding Gains (Losses) on Cash Flow Hedges	'		'
Accumulated Other Comprehensive Income (Loss) [Line Items]	'		'
Balance as of June 29, 2014	-66		'
Other comprehensive income before reclassifications	298		'
(Losses) gains reclassified from accumulated other comprehensive income to net income	-102	[2]	'
Net current-period other comprehensive (loss) income	196		'
Balance as of September 28, 2014	130		'
Accumulated Unrealized Holding Gains (Losses) on Available-For-Sale Investments	'		'
Accumulated Other Comprehensive Income (Loss) [Line Items]	'		'
Balance as of June 29, 2014	1,557		'
Other comprehensive income before reclassifications	-1,759		'
(Losses) gains reclassified from accumulated other comprehensive income to net income	379	[3]	'
Net current-period other comprehensive (loss) income	-1,380		'
Balance as of September 28, 2014	177		'
Accumulated Unrealized Components of Defined Benefit Plans	'		'
Accumulated Other Comprehensive Income (Loss) [Line Items]	'		'
Balance as of June 29, 2014	-17,160		'
Other comprehensive income before reclassifications	66		'
Net current-period other comprehensive (loss) income	66		'
Balance as of September 28, 2014	($17,094)		'
[1]	Derived from audited financial statements
[2]	Amount of after tax gain reclassified from accumulated other comprehensive income into net income located in revenue: $441 gain, cost of goods sold: $250 loss and selling, general and administrative expenses: $89 loss.
[3]	Amount of after tax gain reclassified from accumulated other comprehensive income into net income located in other expense, net

Components_of_Accumulated_Othe1

Components of Accumulated Other Comprehensive Loss (Parenthetical) (Detail) (USD $)	3 Months Ended
In Thousands, unless otherwise specified	Sep. 28, 2014
Accumulated Other Comprehensive Income (Loss) [Line Items]	'
Reclassification from accumulated other comprehensive income	$3,118
Reclassified to Revenue	'
Accumulated Other Comprehensive Income (Loss) [Line Items]	'
Reclassification from accumulated other comprehensive income	441
Reclassified to cost of goods sold	'
Accumulated Other Comprehensive Income (Loss) [Line Items]	'
Reclassification from accumulated other comprehensive income	-250
Reclassified to selling, general, and administrative	'
Accumulated Other Comprehensive Income (Loss) [Line Items]	'
Reclassification from accumulated other comprehensive income	($89)

Long_Term_Debt_and_Other_Borro

Long Term Debt and Other Borrowings - Additional Information (Detail) (USD $)

3 Months Ended

3 Months Ended

3 Months Ended

3 Months Ended

Sep. 28, 2014

Mar. 12, 2014

Sep. 28, 2014

Sep. 28, 2014

Sep. 28, 2014

Sep. 28, 2014

Sep. 28, 2014

Sep. 28, 2014

Sep. 28, 2014

Jun. 29, 2014

31-May-11

Sep. 28, 2014

Jun. 29, 2014

31-May-11

Sep. 28, 2014

Jun. 29, 2014

Jun. 24, 2012

Revolving credit facility

Revolving credit facility

Revolving credit facility

Revolving credit facility

Revolving credit facility

Revolving credit facility

Revolving credit facility

Revolving credit facility

0.50% Notes due 2016

0.50% Notes due 2016

0.50% Notes due 2016

1.25% Notes due 2018

1.25% Notes due 2018

1.25% Notes due 2018

2.625% Notes due 2041

2.625% Notes due 2041

2.625% Notes due 2041

Minimum

Maximum

Prime Rate

Federal Funds Rate

London Interbank Offered Rate (LIBOR)

London Interbank Offered Rate (LIBOR)

Minimum

Maximum

Debt Instrument [Line Items]

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Notes due

'

'

'

'

'

'

'

'

$450,000,000

$450,000,000

$450,000,000

$450,000,000

$450,000,000

$450,000,000

$699,935,000

[1]

$699,935,000

[1]

$700,000,000

Convertible notes interest rate percentage

'

'

'

'

'

'

'

'

'

'

0.50%

'

'

1.25%

'

'

2.63%

Debt instruments maturity date

'

'

'

'

'

'

'

'

'2016

'

'

'2018

'

'

'2041

'

'

Maximum amount of contingent interest rate

'

'

'

'

'

'

'

'

'

'

'

'

'

'

2.10%

'

'

Revolving unsecured credit facility

'

300,000,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Credit Facility Maturity Period

12-Mar-19

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Additional increase in the facility

'

200,000,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Revolving unsecured credit facility maximum borrowing capacity

'

500,000,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Debt instrument basis spread on variable rate

'

'

0.90%

1.50%

0.50%

0.50%

0.00%

0.50%

'

'

'

'

'

'

'

'

'

Total consolidated indebtedness to capitalization ratio

'

'

'

50.00%

'

'

'

'

'

'

'

'

'

'

'

'

'

Consolidated debt to liquidity

1,000,000,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Credit facility outstanding amount

$0

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

[1]

During the quarter-ended September 28, 2014 and June 29, 2014 the market value of the Common Stock was greater than or equal to 130% of the 2041 Note conversion price for 20 or more trading days of the 30 consecutive trading days preceding the quarter end. As a result, the 2041 Notes are convertible at the option of the holder. The carrying amount of the 2041 Notes was classified in current liabilities and the excess of the amount of cash payable, if converted, over the carrying amount of the 2041 Notes was classified as temporary equity in the Company's Consolidated Balance Sheets as of September 28, 2014 and June 29, 2014. Upon closure of a conversion period, all 2041 Notes not converted will be reclassified back to noncurrent liabilities and the temporary equity is reclassified to permanent equity.

Components_of_Notes_Detail

Components of Notes (Detail) (USD $)	3 Months Ended					3 Months Ended			3 Months Ended
In Thousands, except Per Share data, unless otherwise specified	Sep. 28, 2014		Jun. 29, 2014		Jun. 24, 2012	Sep. 28, 2014	Jun. 29, 2014	31-May-11	Sep. 28, 2014	Jun. 29, 2014	31-May-11
	2.625% Notes due 2041		2.625% Notes due 2041		2.625% Notes due 2041	0.50% Notes due 2016	0.50% Notes due 2016	0.50% Notes due 2016	1.25% Notes due 2018	1.25% Notes due 2018	1.25% Notes due 2018
Debt Instrument [Line Items]	'		'		'	'	'	'	'	'	'
Carrying value, long-term	'		'		'	$423,481	$419,561	'	$391,011	$387,338	'
Carrying value, current portion	517,503	[1]	516,586	[1]	'	'	'	'	'	'	'
Unamortized discount	182,432	[1]	183,349	[1]	'	26,519	30,439	'	58,989	62,662	'
Principal amount	699,935	[1]	699,935	[1]	700,000	450,000	450,000	450,000	450,000	450,000	450,000
Remaining amortization period (years)	'26 years 8 months 12 days	[1]	'		'	'1 year 7 months 6 days	'	'	'3 years 7 months 6 days	'	'
Effective interest rate on liability component	4.28%	[1]	'		'	4.29%	'	'	5.27%	'	'
Carrying amount of equity component, net of tax	328,109	[1]	'		'	76,230	'	'	104,895	'	'
Fair Value of Notes (Level 1)	1,542,041	[1]	'		'	573,525	'	'	610,205	'	'
Conversion rate (shares of common stock per $1,000 principal amount of notes)	28.6288	[1]	'		'	15.9527	'	'	15.9527	'	'
Conversion price (per share of common stock)	$34.93	[1]	'		'	$62.69	'	'	$62.69	'	'
If-converted value in excess of par value	$807,144	[1]	'		'	$89,911	'	'	$89,911	'	'
[1]	During the quarter-ended September 28, 2014 and June 29, 2014 the market value of the Common Stock was greater than or equal to 130% of the 2041 Note conversion price for 20 or more trading days of the 30 consecutive trading days preceding the quarter end. As a result, the 2041 Notes are convertible at the option of the holder. The carrying amount of the 2041 Notes was classified in current liabilities and the excess of the amount of cash payable, if converted, over the carrying amount of the 2041 Notes was classified as temporary equity in the Company's Consolidated Balance Sheets as of September 28, 2014 and June 29, 2014. Upon closure of a conversion period, all 2041 Notes not converted will be reclassified back to noncurrent liabilities and the temporary equity is reclassified to permanent equity.

Components_of_Notes_Parentheti

Components of Notes (Parenthetical) (Detail) (USD $)	3 Months Ended		12 Months Ended
	Sep. 28, 2014		Jun. 29, 2014
	D		D
2.625% Notes due 2041	'		'
Debt Instrument [Line Items]	'		'
Principal amount of convertible debt conversion increments	$1,000	[1]	$1,000	[1]
Stock price percentage of conversion price	130.00%		130.00%
Number of days on which common stock sale price was greater than or equal to 130% of conversion price, in a period of 30 consecutive trading days ending on the last trading day of the preceding the quarter	20		20
Number of consecutive trading days period required	'30 days		'30 days
0.50% Notes due 2016	'		'
Debt Instrument [Line Items]	'		'
Principal amount of convertible debt conversion increments	1,000		1,000
1.25% Notes due 2018	'		'
Debt Instrument [Line Items]	'		'
Principal amount of convertible debt conversion increments	$1,000		$1,000
[1]	During the quarter-ended September 28, 2014 and June 29, 2014 the market value of the Common Stock was greater than or equal to 130% of the 2041 Note conversion price for 20 or more trading days of the 30 consecutive trading days preceding the quarter end. As a result, the 2041 Notes are convertible at the option of the holder. The carrying amount of the 2041 Notes was classified in current liabilities and the excess of the amount of cash payable, if converted, over the carrying amount of the 2041 Notes was classified as temporary equity in the Company's Consolidated Balance Sheets as of September 28, 2014 and June 29, 2014. Upon closure of a conversion period, all 2041 Notes not converted will be reclassified back to noncurrent liabilities and the temporary equity is reclassified to permanent equity.

Schedule_of_Recognized_Interes

Schedule of Recognized Interest Cost Relating to Both Contractual Interest Coupon and Amortization of Discount on Liability Component of Notes (Detail) (USD $)	3 Months Ended
In Thousands, unless otherwise specified	Sep. 28, 2014	Sep. 29, 2013
Debt Instrument [Line Items]	'	'
Amortization of interest discount	$8,509	$8,122
2016, 2018 and 2041 Senior Notes	'	'
Debt Instrument [Line Items]	'	'
Contractual interest coupon	6,562	6,562
Amortization of interest discount	8,509	8,122
Amortization of issuance costs	591	591
Total interest cost recognized	$15,662	$15,275

Warrants_and_Convertible_Note_

Warrants and Convertible Note Hedge Arrangements (Detail) (USD $)	3 Months Ended
In Thousands, except Per Share data, unless otherwise specified	Sep. 28, 2014
Warrants	'
Class of Warrant or Right [Line Items]	'
Number of shares available from counterparties	7,179
Exercise price	$75.70
Expiration date range	'August 15 - October 23, 2018
Convertible Note Hedge	'
Class of Warrant or Right [Line Items]	'
Number of shares available from counterparties	7,179
Exercise price	$62.69
0.50% Notes due 2016 | Warrants	'
Class of Warrant or Right [Line Items]	'
Number of shares available from counterparties	7,179
Exercise price	$70.96
Expiration date range	'August 15 - October 21, 2016
0.50% Notes due 2016 | Convertible Note Hedge	'
Class of Warrant or Right [Line Items]	'
Number of shares available from counterparties	7,179
Exercise price	$62.69

Recovered_Sheet2

Commitments and Contingencies - Additional Information (Detail) (USD $)	Sep. 28, 2014	Jun. 29, 2014		Sep. 28, 2014	Sep. 28, 2014	Sep. 28, 2014	Sep. 28, 2014
				Standby Letters of Credit	Operating Lease Cash Collateral	Operating Lease Marketable Securities Collateral	Operating Leases
Commitments and Contingencies [Line Items]	'	'		'	'	'	'
Restricted collateral for leasing arrangements	$149,483,000	$146,492,000	[1]	'	$132,500,000	$11,100,000	'
Operating Lease residual value of guarantee, maximum	'	'		'	'	'	191,200,000
Maximum percentage of aggregate investment value guaranteed	'	'		'	'	'	100.00%
Guarantee Obligation Maximum Exposure	'	'		$14,800,000	'	'	$220,000,000
[1]	Derived from audited financial statements

Schedule_of_Contractual_Cash_O

Schedule of Contractual Cash Obligations Relating to Operating Leases (Detail) (USD $)	Sep. 28, 2014
In Thousands, unless otherwise specified
Operating Leased Assets [Line Items]	'
One year	$15,203
Two years	13,528
Three years	11,761
Four years	5,241
Five years	4,395
Over five years	13,850
Less: Sublease Income	-639
Total	$63,339

Schedule_of_Changes_in_Product

Schedule of Changes in Product Warranty Reserves (Detail) (USD $)	3 Months Ended
In Thousands, unless otherwise specified	Sep. 28, 2014	Sep. 29, 2013
Product Warranty Liability [Line Items]	'	'
Balance at beginning of period	$69,385	$58,078
Warranties issued during the period	24,536	16,753
Settlements made during the period	-24,068	-14,305
Changes in liability for pre-existing warranties	599	-655
Balance at end of period	$70,452	$59,871

Stock_Repurchase_Program_Addit

Stock Repurchase Program - Additional Information (Detail) (USD $)	3 Months Ended				3 Months Ended		0 Months Ended
	Sep. 28, 2014		Sep. 29, 2013	Apr. 29, 2014	Sep. 28, 2014	Sep. 28, 2014	Oct. 09, 2014
				Repurchase Of Equity	Share Repurchase Program Final Settlement	Share Repurchase Program Final Settlement	Share Repurchase Program Final Settlement
				Maximum		Initial delivery	Subsequent Event
Stock Repurchase Program [Line Items]	'		'	'	'	'	'
Authorized repurchase of Company common stock	'		'	$850,000,000	'	'	'
Net shares of settlements to cover tax withholding obligations	120,575		'	'	'	'	'
Amount paid for shares under net share settlements	8,300,000		'	'	'	'	'
Treasury stock purchases	308,422,000		104,285,000	'	250,000,000	'	'
Total Number of Shares Repurchased	3,818,000		'	'	'	3,200,000	300,000
Treasury stock purchases, weighted average share price	$70.01	[1]	'	'	'	'	$72.90
Treasury stock, at cost	$250,000,000		'	'	'	'	'
[1]	Average price paid per share excludes accelerated share repurchases for which cost was incurred during the September 2014 quarter, but that did not settle until the December 2014 quarter. See Collared Accelerated Share Repurchase section below for details regarding average price associated with these transactions.

Schedule_of_Repurchases_under_

Schedule of Repurchases under Repurchase Program (Detail) (USD $)	3 Months Ended
In Thousands, except Per Share data, unless otherwise specified	Sep. 28, 2014		Jun. 29, 2014
Stock Repurchase Program [Line Items]	'		'
Total Number of Shares Repurchased	3,818		'
Total Cost of Repurchase	$296,721		'
Average Price Paid Per Share	$70.01	[1]	'
Amount Available Under Repurchase Program	$534,174		$830,895
[1]	Average price paid per share excludes accelerated share repurchases for which cost was incurred during the September 2014 quarter, but that did not settle until the December 2014 quarter. See Collared Accelerated Share Repurchase section below for details regarding average price associated with these transactions.